US20070190641A1 - Mesoscale polynucleotide amplification device and method - Google Patents

Mesoscale polynucleotide amplification device and method Download PDF

Info

Publication number
US20070190641A1
US20070190641A1 US11/696,926 US69692607A US2007190641A1 US 20070190641 A1 US20070190641 A1 US 20070190641A1 US 69692607 A US69692607 A US 69692607A US 2007190641 A1 US2007190641 A1 US 2007190641A1
Authority
US
United States
Prior art keywords
polynucleotide
flow
appliance
reaction chamber
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/696,926
Inventor
Peter Wilding
Larry Kricka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29219920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20070190641(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/308,199 external-priority patent/US5498392A/en
Application filed by Individual filed Critical Individual
Priority to US11/696,926 priority Critical patent/US20070190641A1/en
Publication of US20070190641A1 publication Critical patent/US20070190641A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/18Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D67/00Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002Organic membrane manufacture
    • B01D67/0023Organic membrane manufacture by inducing porosity into non porous precursor membranes
    • B01D67/003Organic membrane manufacture by inducing porosity into non porous precursor membranes by selective elimination of components, e.g. by leaching
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D67/00Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002Organic membrane manufacture
    • B01D67/0023Organic membrane manufacture by inducing porosity into non porous precursor membranes
    • B01D67/003Organic membrane manufacture by inducing porosity into non porous precursor membranes by selective elimination of components, e.g. by leaching
    • B01D67/0031Organic membrane manufacture by inducing porosity into non porous precursor membranes by selective elimination of components, e.g. by leaching by elimination of at least one of the blocks of a block copolymer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/02Inorganic material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/02Inorganic material
    • B01D71/0213Silicon
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093Microreactors, e.g. miniaturised or microfabricated reactors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502746Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means for controlling flow resistance, e.g. flow controllers, baffles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • B01L7/525Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples with physical movement of samples between temperature zones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00Supporting devices; Holding devices
    • B01L9/52Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
    • B01L9/527Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips for microfluidic devices, e.g. used for lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2325/00Details relating to properties of membranes
    • B01D2325/02Details relating to pores or porosity of the membranes
    • B01D2325/028Microfluidic pore structures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/0059Sequential processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B01L2200/027Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0647Handling flowable solids, e.g. microscopic beads, cells, particles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/143Quality control, feedback systems
    • B01L2200/146Employing pressure sensors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/143Quality control, feedback systems
    • B01L2200/147Employing temperature sensors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0645Electrodes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0681Filter
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1805Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
    • B01L2300/1822Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using Peltier elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1838Means for temperature control using fluid heat transfer medium
    • B01L2300/185Means for temperature control using fluid heat transfer medium using a liquid as fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1861Means for temperature control using radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/806Electrical property or magnetic property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Definitions

  • This invention relates generally to methods and apparatus for conducting analyses. More particularly, the invention relates to the design and construction of small, typically single-use, modules capable of analyses involving polymerase chain reaction (PCR).
  • PCR polymerase chain reaction
  • Shoji et al. reported the use of a miniature blood gas analyzer fabricated on a silicon wafer.
  • Shoji et al. Sensors and Actuators , 15:101-107 (1988).
  • Sato et al. reported a cell fusion technique using micromechanical silicon devices. Sato et al., Sensors and Actuators , A21-A23:948-953 (1990).
  • Ciba Corning Diagnostics Corp. USA has manufactured a microprocessor-controlled laser photometer for detecting blood clotting.
  • Micromachining technology originated in the microelectronics industry. Angell et al., Scientific American , 248:44-55 (1983). Micromachining technology has enabled the manufacture of microengineered devices having structural elements with minimal dimensions ranging from tens of microns (the dimensions of biological cells) to nanometers (the dimensions of some biological macromolecules). This scale is referred to herein as “mesoscale”. Most experiments involving mesoscale structures have involved studies of micromechanics, i.e., mechanical motion and flow properties. The potential capability of mesoscale structures has not been exploited fully in the life sciences.
  • PCR polymerase chain reaction
  • nucleoside triphosphates and two oligonucleotides with different sequences, complementary to sequences that lie on opposite strands of the template DNA and which flank the segment of DNA that is to be amplified (“primers”).
  • the reaction components are cycled between a higher temperature (e.g., 94° C.) for dehybridizing (“melting”) double stranded template DNA, followed by a lower temperature (e.g., 65° C.) for annealing and polymerization.
  • a higher temperature e.g., 94° C.
  • melting dehybridizing
  • annealing and polymerization e.g., 65° C.
  • up to 1 ⁇ g of target DNA up to 2 kb in length can be obtained from 30-35 cycles of amplification with only 10 ⁇ 6 ⁇ g of starting DNA.
  • Machines for performing automated PCR chain reactions using a thermal cycler are available (Perkin Elmer Corp.)
  • PCR amplification has been applied to the diagnosis of genetic disorders (Engelke et al., Proc. Natl. Acad. Sci ., 85:544 (1988), the detection of nucleic acid sequences of pathogenic organisms in clinical samples (Ou et al., Science , 239:295 (1988)), the genetic identification of forensic samples, e.g., sperm (Li et al., Nature , 335:414 (1988)), the analysis of mutations in activated oncogenes (Farr et al., Proc. Natl. Acad.
  • PCR assays can be used in a wide range of applications such as the generation of specific sequences of cloned double-stranded DNA for use as probes, the generation of probes specific for uncloned genes by selective amplification of particular segments of cDNA, the generation of libraries of cDNA from small amounts of mRNA, the generation of large amounts of DNA for sequencing, and the analysis of mutations.
  • PCR analyses There is a need for convenient rapid systems for PCR analyses, which could be used clinically in a wide range of potential applications in clinical tests such as tests for paternity, and genetic and infectious diseases.
  • An object of the invention is to provide analytical systems with optimal reaction environments that can analyze microvolumes of sample, detect very low concentrations of a polynucleotide, and produce analytical results rapidly. Another object is to provide easily mass produced, disposable, small (e.g., less than 1 cc in volume) devices having mesoscale functional elements capable of rapid, automated PCR analyses of a preselected cell or cell-free sample, in a range of applications. It is a further object of the invention to provide a family of such devices that individually can be used to implement a range of rapid clinical tests, e.g., tests for viral or bacterial infection, tests for cell culture contaminants, or tests for the presence of recombinant DNA or a gene in a cell, and the like.
  • the invention provides a family of small, mass produced, typically one-use devices for conducting a polynucleotide polymerization reaction to enable the rapid amplification of a polynucleotide in a sample.
  • the device comprises a solid substrate, on the order of a few millimeters thick and approximately 0.2 to 2.0 centimeters square, that is microfabricated to define a sample inlet port and a mesoscale flow system.
  • the flow system of the device includes a sample flow channel extending from the inlet port, and a polynucleotide polymerization reaction chamber in fluid communication with the flow channel polynucleotide.
  • the term “mesoscale” is used herein to define chambers and flow passages having a cross-sectional dimension on the order of 0.1 ⁇ m to 500 ⁇ m, with preferred reaction chamber widths on the order of 2.0 to 500 ⁇ m, more preferably 3-100 ⁇ m. For many applications, channels of 5-50 ⁇ m widths will be useful. Chambers in the substrate wherein amplification takes place may have somewhat larger dimensions, e.g., 1-5 mm. Preferred reaction chamber and channel depths are on the order of 0.1 to 100 ⁇ m, typically 2-50 ⁇ m. The flow channels in the devices, leading to the reaction chambers, have preferred widths on the order of 2.0 to 200 ⁇ m and depths on the order of 0.1 to 100 ⁇ m.
  • the devices may be utilized to implement a polymerization chain reaction (PCR) in the reaction chamber.
  • the reaction chamber may be provided with reagents for PCR including a sample polynucleotide, polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence that is complementary to the sample polynucleotide, wherein the first and second primers define the termini of the polymerized polynucleotide product.
  • PCR polymerization chain reaction
  • the device also may include means for thermally cycling the contents of the PCR chamber, such that, in each cycle, the temperature is controlled to 1) dehybridize (“melt”) double stranded polynucleotide, 2) anneal the primers to single stranded polynucleotide, and 3) synthesize amplified polynucleotide between the primers.
  • the PCR chamber may comprise one section which is thermally cycled sequentially to the required temperatures for PCR.
  • the PCR chamber may comprise two or more sections, set at the different temperatures required for dehybridization, annealing and polymerization, in which case the device further comprises means for cycling the contents of the chamber between the sections to implement the PCR, e.g., a pump or other means as disclosed herein.
  • the device may further include means for detecting the amplified polynucleotide.
  • the devices may be used to implement a variety of automated, sensitive and rapid polynucletide analyses, including analyses for the presence of polynucleotides in cells or in solution, or for analyses for a virus or cell types using the presence of a particular polynucleotide as a marker.
  • the solid substrate comprises a chip, containing the mesoscale flow system and the reaction chamber(s).
  • the mesoscale flow channels and reaction chambers may be designed and fabricated from silicon and other solid substrates using established micromachining methods.
  • the mesoscale flow systems in the devices may be constructed by microfabricating flow channels and one or more reaction chambers into the surface of the substrate, and then adhering a cover, e.g., a transparent glass cover, over the surface.
  • the devices analyze microvolumes ( ⁇ 10 ⁇ L) of a sample, introduced into the flow system through an inlet port defined, e.g., by a hole communicating through the substrate or the cover.
  • the volume of the mesoscale flow system typically will be ⁇ 5 ⁇ L, and the volume of individual channels, chambers, or other functional elements are often less than 1 ⁇ L, e.g., in the nanoliter or even picoliter range.
  • Polynucleotides present in very low concentrations, (e.g. nanogram quantities) can be rapidly amplified ( ⁇ 10 minutes) and detected. After a polynucleotide polymerization assay is complete, the devices may be discarded.
  • the chips typically will be used with an appliance which contains a nesting site for holding the chip, and which mates one or more input ports on the chip with one or more flow lines in the appliance.
  • a biological fluid sample suspected. to contain a particular polynucleotide is applied to the inlet port of the substrate, the chip is placed in the appliance and a pump, e.g., in the appliance, is actuated to force the sample through the flow system.
  • a sample may be injected into the chip by the appliance.
  • Reagents required for the assay such as a polymerase, may be added to the polynucleotide sample prior to injection into the chip.
  • reagents necessary to complete the assay can be injected into the reaction chamber from a separate inlet port, e.g., by the appliance. Fluid samples and reagents may also enter the mesoscale flow system by capillary action.
  • the devices may be utilized to perform a PCR assay, and the temperature of one or more section(s) in the reaction chamber can be regulated by, e.g., providing one or more electrical resistance heaters in the substrate near the reaction chamber, or by using a pulsed laser or other source of electromagnetic energy directed to the reaction chamber.
  • the appliance may include electrical contacts in the nesting region which mate with contacts integrated into the structure of the chip, e.g., to power electrical resistance heating of the reaction chamber.
  • a cooling element may also be provided in the appliance to assist in the thermal regulation of the reaction chamber.
  • the appliance may be provided with conventional circuitry sensors in communication with sensors in the device for thermally regulating the PCR temperature cycles required for the dehybridization and polymerization reactions.
  • the amplified polynucleotide produced by the polynucleotide amplification reaction in the mesoscale reaction chamber can be collected through a port in the substrate and detected, e.g., by gel electrophoresis or any other method.
  • a mesoscale detection region may be microfabricated in the substrate, in fluid communication with the reaction chamber in the device, as a part of the mesoscale flow system.
  • the detection region may include a labeled binding moiety, such as a labeled polynucleotide or antibody probe, capable of detectably binding with the amplified polynucleotide.
  • the presence of polymerized polynucleotide product in the detection region can be detected, e.g., by optical detection of agglutination of the polymerized polynucleotide and the binding moiety through a glass cover over the detection region or through a translucent section of the substrate itself.
  • a positive assay may also be indicated by detectable changes in sample fluid flow properties such as changes in pressure or electrical conductivity at different points in the flow system upon production of polymerized polynucleotide in the reaction chamber.
  • the device comprises a mesoscale flow system which includes a polynucleotide amplification reaction chamber, and a detection region is used in combination with an appliance which includes sensing equipment such as a spectrophotometer capable of reading a positive result through an optical window, e.g., disposed over the detection region.
  • the appliance may also be designed to receive electrical signals indicative of a pressure reading, conductivity, or the like, sensed in the reaction chamber, the detection region, or some other region of the flow system.
  • the substrate may comprise a plurality of detection/reaction chambers to enable the rapid parallel detection of polynucleotides in a mixture.
  • the mesoscale flow system may include protrusions, or a section of reduced cross sectional area, to enable the lysis of cells in the microsample prior to delivery to the reaction chamber. Sharp edged pieces of silicon, trapped in the flow path, can also be used as a lysis means.
  • the mesoscale flow system also may include a cell capture region comprising a binding moiety, e.g., immobilized on a wall of a flow channel, which binds a particular type of cell in a heterogeneous cell population at a low fluid flow rate, and at a greater flow rate, releases the cell type prior to delivery of the cells to a cell lysis region then to a reaction chamber.
  • a cell capture region comprising a binding moiety, e.g., immobilized on a wall of a flow channel, which binds a particular type of cell in a heterogeneous cell population at a low fluid flow rate, and at a greater flow rate, releases the cell type prior to delivery of the cells to a cell lysis region then to a reaction chamber.
  • intracellular DNA or RNA is isolated from a selected cell subpopulation and delivered to the mesoscale reaction chamber for polynucleotide analysis in one device.
  • magnetic beads may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance.
  • a polynucleotide probe may be immobilized on the magnetic beads enabling the beads to bind to amplified polynucleotide in the reaction chamber.
  • Magnetic beads containing an immobilized polynucleotide probe may be, e.g., transported through the flow system to the reaction chamber at the end of an assay to bind to the polymerized polynucleotide product. The bound polynucleotide may then be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port.
  • the devices can provide a rapid test for the detection of pathogenic bacteria or viruses, or for the presence of certain cell types, or the presence of a gene or a recombinant DNA sequence in a cell.
  • the devices as disclosed herein are all characterized by a mesoscale flow system including a PCR chamber which is used to amplify a polynucleotide in a sample, which may be provided with polymerase and other reagents required for PCR.
  • the device may be used to amplify a polynucleotide in a wide range of applications. At the conclusion of the assay the chip typically is discarded. TABLE 1 Feature Benefit Flexibility No limits to the number of chip designs or applications available.
  • FIG. 1 is a schematic longitudinal cross sectional view of a device according to the invention that includes a solid substrate 14 , on which is machined mesoscale flow channel 20 connected to inlet ports 16 and PCR reaction chamber 22 , with a transparent cover 12 adhered to the surface of the substrate.
  • FIG. 2 is a perspective view of the device of FIG. 1 .
  • FIG. 3A is a schematic illustration of an analytical device 10 nested within a schematically illustrated appliance 50 , which may be used to support the device 10 and which includes heating element 57 for regulating the temperature of the reaction chamber 22 in device 10 .
  • FIG. 3B is a schematic illustration of an analytical device 10 nested within appliance 50 , which may be used to support the device 10 and which includes the heating element 53 for regulating the temperature of the reaction chamber 22 in device 10 .
  • FIG. 4 is a schematic longitudinal cross sectional view of a device according to the invention that includes a solid substrate 14 , on which is machined mesoscale flow channel 20 connected to inlet ports 16 and PCR reaction chamber sections 22 , with a transparent cover 12 adhered to the surface of the substrate.
  • FIG. 5 is a perspective view of the device of FIG. 4 .
  • FIG. 6A is a schematic illustration of analytical device 10 nested within appliance 50 , which may be used to support the device 10 , and which includes heating elements 57 for regulating the temperature of the reaction chamber sections 22 in device 10 .
  • FIG. 6B is a schematic illustration of analytical device 10 nested within appliance 50 , which may be used to support the device 10 and which includes heating element 57 for regulating the temperature of the reaction chamber section 22 A in device 10 .
  • FIG. 7 is a schematic plan view of a substrate 14 microfabricated with mesoscale PCR chamber sections 22 A and 22 B, in fluid communication with a detection chamber. comprised of a fractally bifurcating system of flow channels 40 symmetrically disposed on the substrate.
  • FIG. 8 is a cross sectional perspective view of a flow channel 20 in substrate 14 with cell or debris filtering protrusions 80 extending from a wall of the channel.
  • FIG. 9 is a cross sectional perspective view of a flow channel 20 in substrate 14 with cell piercing protrusions 90 extending from a wall of the channel.
  • FIG. 10 is a schematic plan view of a mesoscale PCR analytical device including PCR chamber sections 22 A and 22 B microfabricated in the silicon substrate 14 .
  • FIG. 11 is a schematic plan view of another mesoscale PCR analytical device including a PCR chamber 22 A microfabricated in the silicon substrate 14 .
  • FIG. 12 is a schematic plan view of an analytical device fabricated with a series of mesoscale chambers suitable for implementing a variety of functions including cell sorting, cell lysing and PCR analysis.
  • FIG. 13 is a schematic plan view of an analytical device fabricated with a pair of fractally bifurcating flow channels 40 .
  • FIGS. 14, 15 and 16 illustrate top plan views of different embodiments of a mesoscale filter 24 microfabricated in flow channel 20 in an analytical device 10 .
  • FIG. 17 is a schematic perspective view of an apparatus 60 used in combination with device 10 for viewing the contents of device 10 .
  • FIG. 18 is a schematic cross sectional view of the apparatus 60 of FIG. 17 .
  • the invention provides a family of small, mass produced, typically one-use devices for conducting a polynucleotide polymerization reaction to enable the rapid amplification of a polynucleotide in a fluid sample.
  • the devices comprise a solid substrate, typically on the order of a few millimeters thick and approximately 0.2 to 2.0 centimeters square, microfabricated to define a sample inlet port and a mesoscale flow system.
  • the mesoscale flow system includes at least one sample flow channel extending from the inlet port and at least one polynucleotide polymerization reaction chamber in fluid communication with the flow channel.
  • the arrangement of channels, chambers, and multiple ports facilitates the sequential, properly timed, and volumetrically correct addition of sample and reagents within the device.
  • the reaction chamber and the flow channels preferably have a mesoscale dimension, i.e. a cross sectional dimension on the order of 0.1 to 500 ⁇ m.
  • the preferred depth of the reaction chamber is on the order of 0.7 to 100 ⁇ m, and preferred width- is on the order of 2.0 to 500 ⁇ m.
  • the preferred depth of the flow channels is on the order of 0.1 to 100 ⁇ m, and the preferred. width is on the order of 2.0 to 200 ⁇ m.
  • the devices may be utilized to conduct a polymerase chain reaction (PCR) in the reaction chamber (PCR chamber).
  • PCR chamber is provided with reagents required for a polymerase chain reaction including the sample polynucleotide, a polymerase such as Taq polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence complementary to the polynucleotide, wherein the first and second primers define the termini of the polymerized product polynucleotide.
  • a polymerase such as Taq polymerase
  • nucleoside triphosphates a first primer hybridizable with the sample polynucleotide
  • second primer hybridizable with a sequence complementary to the polynucleotide wherein the first and second primers define the termini of the polymerized product polynucleotide.
  • the polymerase chain reaction may be performed, according to methods established in the art (Maniatis et al., Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, 1989).
  • the device may include means for thermally cycling the contents of the chamber such that, in each cycle, temperature is controlled to dehybridize double stranded polynucleotide to produce single stranded polynucleotide, and then to anneal the primers and allow polynucleotide polymerization.
  • other polynucleotide. polymerization reactions known in the art may be utilized including the isothermal in vitro amplication of DNA by a restriction enzyme/DNA polymerase system. Walker etal., Proc. Natl. Acad. Sci U.S.A ., 89:392-396 (1992).
  • a ligase chain reaction also may be utilized. Backman, K. Clin. Chem ., 38:457-458 (1992).
  • the device also may include means for detecting the amplified polynucleotide.
  • the devices may be used to implement a variety of automated, sensitive and rapid polynucleotide analyses including the analysis of polynucleotides in cells or in solution. At the conclusion of the assay the devices typically are discarded. The use of disposable devices eliminates contamination among samples. The sample and reaction mixture at all times can remain entombed, and the low volume simplifies waste disposal.
  • Analytical devices having mesoscale flow channels and reaction chambers can be designed and fabricated in large quantities from a solid substrate material. They can be sterilized easily. Silicon is preferred because of the well-developed technology permitting its precise and efficient fabrication, but other materials may be used, such as polymers including polytetrafluoro-ethylenes.
  • the sample inlet and other ports, the mesoscale flow system, including the sample flow channel(s) and the reaction chamber(s) and other functional elements, thus may be fabricated in expensively in large quantities from a silicon substrate by any of a variety of micromachining methods known to those skilled in the art.
  • micromachining methods include film deposition processes such as spin coating and chemical vapor deposition, laser fabrication or photolithographic techniques such as UV or X-ray processes, or etching methods which may be performed by either wet chemical processes or plasma processes. (See, e.g., Manz et al., Trends in Analytical Chemistry 10: 144-149 (1991)).
  • Flow channels of varying widths and depths can be fabricated with mesoscale dimensions.
  • the silicon substrate containing a fabricated mesoscale flow channel may be covered and sealed with a thin anodically bonded glass cover.
  • Other clear or opaque cover materials may be used.
  • two silicon substrates can be sandwiched, or a silicon substrate can be sandwiched between two glass covers.
  • the use of a transparent cover results in a window which facilitates dynamic viewing of contents in the mesoscale flow system.
  • Other fabrication approaches may be used.
  • a PCR analysis may be conducted in the reaction chamber of the devices.
  • the device 10 may include a silicon substrate 14 microfabricated with inlet ports 16 , a mesoscale flow channel 20 , and PCR chamber 22 .
  • the polynucleotide sample and the reagents required for the polymerization reaction are added, and the products withdrawn (if necessary) through flow channel 20 and reaction chamber 22 through inlet ports 16 which are fabricated on either end of the flow channel 20 .
  • the substrate 14 is covered with a glass or plastic coverslip 12 .
  • the device 10 may be used in combination with an appliance, such as appliance 50 shown schematically in FIG. 3A .
  • Appliance 50 includes a nesting site 58 for holding the device 10 , and for registering ports, e.g., ports 16 on device 10 , with a flow line 56 in the appliance.
  • a pump 52 in appliance 50 is used to deliver a sample and/or reagents from flow line 56 in the appliance to the reaction chamber 22 via the inlet ports 16 .
  • the appliance 50 may include a heating/cooling element 57 for controlling the temperature within the PCR chamber, e.g., an electrical heating element and/or a refrigeration coil.
  • the electrical heating element may alternatively be integrated into the substrate 10 , with contacts for power mated to matching electrical contacts in the appliance below the reaction chamber 22 .
  • the appliance may include a heating means 53 , such as a laser, or other source of electromagnetic energy, disposed over the reaction chamber in device 10 .
  • the laser may be disposed in the appliance below the reaction chamber.
  • a microprocessor in the appliance may be used to regulate the heating element in order to provide a temperature cycle in the PCR chamber between a temperature suitable for dehybridization, e.g.
  • thermocouple may also be provided in the substrate in electrical contact with the appliance, to allow the microprocessor to detect and maintain the temperature cycles in the reaction chamber.
  • a cooling element such as a miniature thermoelectric heat pump (Materials Electronic Products Corporation, Trenton, New Jersey), may also be included in the appliance for adjusting the temperature of the reaction chamber.
  • the temperature of the reaction chamber can be regulated by a timed laser pulse directed at the reaction chamber through glass cover 12 , so as to allow sequential heating and cooling of the sample to the required temperatures for the PCR cycle.
  • the thermal properties of silicon enable a rapid heating and cooling cycle.
  • the analytical devices also may be utilized in combination with an appliance for viewing the contents of the mesoscale channels in the devices.
  • the appliance in one embodiment may comprise a microscope for viewing the contents of the mesoscale channels in the devices.
  • a camera may be included in the appliance, as illustrated in the appliance 60 shown schematically in FIGS. 17 and 18 .
  • the appliance 60 is provided with a housing 62 , a viewing screen 64 and a slot 66 for inserting a chip into the appliance.
  • the appliance 60 also includes a video camera 68 , an optical system 70 , and a tilt mechanism 72 for holding device 10 , and allowing the placement and angle of device 10 to be adjusted manually.
  • the optical system 70 may include a lens system for magnifying the channel contents, as well as a light source.
  • the video camera 68 and screen 64 allow changes in sample fluid properties, such as flow properties or color, induced by the presence of polymerized polynucleotide, to be monitored visually and optionally recorded using the appliance.
  • a mesoscale PCR chamber may be microfabricated with multiple sections, e.g., two sections 22 A and 22 B, connected by flow channel 20 B.
  • section 22 A is heated to a temperature suitable for dehybridization
  • section 22 B is heated to a temperature suitable for annealing and polymerization.
  • the device 10 may be placed in appliance 50 ( FIG. 6A ).
  • the appliance 50 is provided with means 57 for controlling the temperature of the reaction chamber sections.
  • a laser may be used to heat the sections.
  • thermocouple can be included in the substrate to monitor the temperatures of the sections of the reaction chamber, and its output may be used to control thermal input with the aid of a microprocessor.
  • a pump 52 in the appliance is used to deliver the polynucleotide sample and the required PCR reagents from flow line 56 through inlet port 16 A to section 22 A.
  • the pump 52 which also may be controlled by a microprocessor in the appliance, is then used to cycle the sample continually between sections 22 A and 22 B, through channel 20 B to implement a continual polymerase chain reaction cycle, while port 16 B serves as a vent.
  • the pump 52 in appliance 50 may be used to deliver the sample through port 16 B and line 56 in the appliance to port 59 to recover the product.
  • three or more chambers may be used, each of which are maintained at a temperature suitable for conducting a particular reaction.
  • a heating element may be used to heat section 22 A to a temperature suitable for dehybridization of double stranded DNA, e.g. 94° C., while section 22 B and channel 20 B, which connects sections 22 A and 22 B, are spaced apart from section 22 A such that upon transport of a heated sample from section 22 A to section 22 B, heat is dissipated sufficiently to permit the temperature of the sample to fall to the temperature required for annealing and polymerization before the sample is returned to section 22 A for further cycling.
  • This may be achieved readily as silicon has a relatively high thermal conductivity and the area of interface between the liquid sample and the substrate is quite high.
  • microprocessors in the appliance 50 are used to control pump 52 , which regulates the flow cycle of the sample between sections 22 A and 22 B.
  • pump 52 which regulates the flow cycle of the sample between sections 22 A and 22 B.
  • a dynamic thermal equilibrium creates a temperature gradient along the flow path between the chambers, and appropriate temperatures are achieved in both using a single heating source.
  • Other designs are possible. For example, the annealing and polymerization reactions could be implemented in different sections of a single PCR chamber, set at different optimized temperatures.
  • the polymerase chain reaction may be implemented using any thermostable polynucleotide polymerase, such as Taq polymerase.
  • Reagents such as Taq polymerase may be added to a sample and then delivered through an inlet port to the mesoscale reaction chamber, or the reagents may be delivered to the reaction chamber independently of the sample through a separate inlet port.
  • the capacity of the devices is very small and therefore the amount of sample fluid required for an analysis is low.
  • the volume of each groove is 10 ⁇ 3 ⁇ L and the total volume of the 500 grooves is 0.5 ⁇ L.
  • the low volume of the mesoscale flow systems allows assays to be performed on very small amounts of a liquid sample ( ⁇ 5 ⁇ L).
  • the mesoscale flow systems of the devices may be microfabricated with microliter volumes, or alternatively nanoliter volumes or less, which advantageously limits the amount of sample and/or reagent fluids required for an assay.
  • the devices of the invention provide mesoscale polynucleotide polymerization reaction chambers which may be used for the rapid amplification of a polynucleotide in a biological fluid sample.
  • the device may also include a means for detecting the amplified polynucleotide product disposed either in the substrate or in the appliance.
  • the presence of amplified polynucleotide product in the device can be detected by any of a number of methods including monitoring the pressure or electrical conductivity of sample fluids entering and/or exiting the reaction chamber in the mesoscale flow system.
  • the presence of amplified polynucleotide product also can be detected by a binding assay with a labeled probe such as a labeled oligonucleotide or antibody probe, or by gel electrophoresis.
  • the amplified polynucleotide product can be detected by using a detection chamber fabricated in the mesoscale flow system in the substrate in fluid communication with the reaction chamber.
  • the detection chamber is provided with a binding moiety capable of binding to the amplified polynucleotide.
  • the binding moiety may comprise, e.g., a polynucleotide or antibody probe.
  • the detection chamber may be fabricated in accordance with methods disclosed in U.S. Ser. No. ______ [Attorney Docket No. UPA001 (8261/2)], Mesoscale Detection Structures, the disclosure of which is incorporated herein by reference.
  • the device may be used in combination with an appliance containing a microprocessor for detecting and recording data obtained during an assay.
  • the mesoscale detection chamber may be provided with an inert substrate, e.g., a bead or other particle, capable of binding to the polymerized polynucleotide, to cause detectable agglomeration of the beads in the presence of polymerized polynucleotide product.
  • Particle induced agglomeration can be enhanced by the attachment of a binding moiety, such as an antibody, to the particle.
  • Antibodies or other binding moieties capable of binding to the polymerized polynucleotide may be introduced into the detection chamber, or may be coated, either chemically or by absorption, onto the surface of the detection region, or alternatively, onto the surface of an inert particle in the detection region, to induce binding, giving a positive test for the polynucleotide.
  • Techniques for the chemical activation of silaceous surfaces are well developed, particularly in the context of chromatography. (See, e.g., Haller in: Solid Phase Biochemistry , W. H. Scouten, Ed., John Wiley, New York, pp 535-597 (1983); and Mandenius et al., Anal. Biochem. 170: 68-72 (1988)).
  • the binding moiety may comprise an antibody, and immunoassay techniques known in the art can be performed in the detection region. (See, e.g., Bolton et al., Handbook of Experimental Immunology , Weir D.M., Ed., Blackwell Scientific Publications, Oxford, 1986, Vol. 1, Chapter 26, for a general discussion of immunoassays).
  • An optically detectable label such as a fluorescent molecule or fluorescent bead may be attached to the binding moiety to enhance detection of the polymerized polynucleotide.
  • a second labeled substance such as a fluorescent labeled antibody may be delivered through the flow system to bind to the bound polynucleotide/binding moiety complex in the detection region to produce a “sandwich” including an optically detectable moiety indicative of the presence of the analyte.
  • the binding of the amplified polynucleotide to the binding moiety in the detection region may be detected, e.g., optically, either visually or by machine, through a transparent window disposed over the detection region.
  • the production of amplified polynucleotide may be detected by the addition of a dye such as ethidium bromide, which exhibits enhanced fluorescence upon binding to double stranded polynucleotide.
  • a dye such as ethidium bromide
  • the detection chamber may also be provided with a labelled complementary polynucleotide capable of binding to one of the strands of the amplified polynucleotide, e.g., a labeled polynucleotide immobilized on a bead, to enable the detection of polymerized polynucleotide product by means of bead agglutination.
  • a labelled complementary polynucleotide capable of binding to one of the strands of the amplified polynucleotide, e.g., a labeled polynucleotide immobilized on a bead, to enable the detection of polymerized polynucleotide product by means of bead agglutination.
  • Polynucleotide. hybridization techniques known in the art may be utilized. Maniatis et al., Molecular Cloning: A Laboratory Manual , 2nd ed., Cold Spring Harbor Press, 1989); Vener e
  • Polynucleotide polymerization also can be detected using a detection region sensitive to flow restriction caused by the presence of polymerized polynucleotide produced in the reaction chamber, as is disclosed in USSN [Attorney Docket No. UPA002 (8261/3)], Analysis Based on Flow Restriction, the disclosure of which is incorporated herein by reference.
  • the presence of amplified polynucleotide also may be detected by sensing the pressure or electrical conductivity of the fluid samples entering and exiting the flow system. The conductivity may be measured, e.g., using electrical contacts which extend through the substrate and which mate with electrical contacts in an appliance used in combination with the device. Electrical contacts can be fabricated by known techniques of thermal gradient zone melting. (See Zemel et al., in: Fundamentals and Applications of Chemical Sensors , D. Schuetzle and R. Hammerle, Eds., ACS Symposium Series 309, Washington, D.C., 1986, p. 2.)
  • Amplified polynucleotide in the reaction chamber can be detected by monitoring the pressure of-the sample fluids.
  • the pressure detectors 54 connected to sample fluid entering and exiting the mesoscale flow system through ports 16 will allow the detection of pressure decreases caused by the presence of polymerized product and resulting clogging or flow restriction.
  • a mesoscale pressure sensor also may be fabricated directly on the silicon substrate. Angell et al., Scientific American 248: 44-55 (1983).
  • Polynucleotide polymerization can be detected by the use of a mesoscale flow system sensitive to flow restriction, constructed with a “fractal” pattern, i.e., a pattern of serially bifurcating flow channels.
  • the fractally bifurcating channels may be fabricated on a silicon substrate with reduced dimensions at each bifurcation, providing sequentially narrower flow channels.
  • FIG. 7 shows a schematic plan view of a substrate 14 fabricated with a fractally bifurcating system of flow channels 40 connected via channel 20 to ports 16 and a PCR reaction chamber comprising sections 22 A and 22 B. The presence of amplified polynucleotide product in a sample will influence the flow characteristics within the fractal.
  • the channels 40 in this embodiment are symmetrically disposed and have a sequentially narrower diameter towards the center of the fractal. Flow through this fractal is sensitive to changes in fluid viscosity caused by the presence of polymerized product.
  • a more complex fractal flow system may be utilized, as illustrated in FIG. 13 .
  • FIG. 13 illustrates a pair of fractally bifurcating flow channels. 40 A and 40 B.
  • the fractal flow channel 40 A is constructed with sequentially narrower flow channels towards the center of the fractal, resulting in an enhanced sensitivity to flow restriction.
  • Flow restriction in the fractal region can be detected, e.g., optically, through a transparent cover over the detection region.
  • one or more pressure sensors may be utilized to detect pressure.
  • Changes in conductivity upon polynucleotide production also may be readily detected through electrical conductivity sensors in contact with the flow region. For example, clogging of the fractal region 40 which blocks flow from inlet port 16 A to outlet port 16 B could be detected by a conventional conductivity probe 17 whose output is indicative of the presence or absence of aqueous fluid in the outflow channel.
  • Binding moieties such as labeled antibodies or polynucleotide probes may be included in the fractal region, e.g. immobilized, or on a solid phase reactant such as a bead, to bind to the product polynucleotide to induce flow restriction in the fractal flow path.
  • the mesoscale flow system includes a chamber for lysing cells from a sample in preparation for downstream polynucleotide analysis.
  • the devices also may include a region adapted to separate a particular type of cell in a heterogeneous cell population.
  • the cell separation region includes immobilized binding moieties immobilized on structures within the substrate which selectively reversibly bind a target cell via a characteristic cell surface molecule such as a protein. Other cells in the sample pass downstream and are discarded into a sump or through an exit port.
  • Flow may be continued to wash the cells, e.g., with a flow of buffer.
  • the washed cells are sheared from the surfaces, released from the separation region, and move downstream to a lysis means, which lyse the cells prior to PCR analysis of an intracellular RNA or DNA molecule.
  • the cell lysing means typically is disposed in the flow path between the cell separation region (if any) and the polynucleotide polymerization reaction chamber to allow the cells to be lysed prior to analysis for an intracellular polynucleotide.
  • the cell lysing means may comprise cell membrane piercing protrusions 90 extending from a surface of a flow channel 20 . As fluid flow is forced through the piercing protrusion 90 , cells are ruptured.
  • the cell lysis means may simply comprise a region of restricted cross-sectional dimension which implements cell lysis upon application of sufficient flow pressure.
  • the cell lysis means may also comprise sharp edged pieces of silicon trapped within a mesoscale lysis chamber.
  • An appliance which includes means, such as a pump, for forcing the cell containing sample into the cell lysis means, causes cell lysis upon application of sufficient flow pressure, and subsequently delivers the sample through the flow system to the reaction chamber.
  • the cell lysis means may comprise a cell lysing agent. Cell lysing agents known in the art may be utilized.
  • Reagents may be added to the reaction chamber from a separate inlet port in the substrate in fluid communication with the reaction chamber.
  • a filter microfabricated in the flow channel on the silicon substrate, can be used to filter cell debris prior to polynucleotide analysis.
  • the filter 24 in device 10 may comprise a mesoscale flow channel of reduced diameter in comparison with channel 20 .
  • sample flows from sample flow channel 20 A through filter 24 .
  • Sample filtrate then exits filter 24 and flows through channel 20 B.
  • the filter 24 is microfabricated with depths and widths on the order of 0-1 to 20 ⁇ m, while flow channels 20 A and 20 B have maximum depths and widths on the order of approximately 500 ⁇ m. As illustrated in FIG.
  • the surface of a flow channel 20 may also include protrusions 80 constituting a cellular sieve for separating cells by size upstream from the PCR analysis chamber. As cell samples are flowed through the flow channel, typically under low pressure, only cells small enough to pass between the protrusions 80 reach downstream functional elements. These cells subsequently can be delivered through a cell lysis region, then to a PCR reaction chamber for analysis.
  • paramagnetic or ferromagnetic beads may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance.
  • the beads may be used to transport reagents between functional elements in the device, or to displace a sample, a reagent or a reaction mixture.
  • a polynucleotide probe may be immobilized on the magnetic beads enabling the beads to bind to amplified polynucleotide.
  • Magnetic beads comprising a coating of polynucleotide probe may be transported through the flow system to the reaction chamber at the end of an assay to bind to the polymerized polynucleotide product.
  • the bound polymerized polynucleotide then may be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port.
  • FIG. 10 One embodiment of the invention, illustrated in FIG. 10 , is a device 10 comprising a substrate 14 microfabricated with a mesoscale PCR chamber comprising sections 22 A and 22 B, which are connected by flow path 20 B.
  • the PCR chip 10 is used in combination with an appliance, such as appliance 50 , shown in FIG. 6A , which contains a nesting site for holding the chip.
  • the appliance SO is provided with flow paths 56 mated to ports 16 A, 16 B, 16 C and 16 D in device 10 .
  • the appliance also includes valves that allow the ports 16 A, 16 B, 16 C and 16 D to be mechanically opened and closed.
  • the flow systems of the devices may be maintained at a hydraulically full volume, and valves in the appliance, or alternatively, in the devices, may be utilized to direct fluid flow.
  • Sections 22 A and 22 B of the PCR chamber are heated to 94° C. and 65° C., respectively, to provide a melting temperature and an annealing temperature as required for PCR.
  • reaction chamber sections maybe heated by means of an electrical contact-integrated in the substrate below the sections, which can mate with electrical contacts in the appliance.
  • an optical laser may be used to heat the reaction chamber sections through a glass cover disposed over the substrate.
  • a heat sensor may be provided in the substrate, in electrical contact with the appliance.
  • a microprocessor in the appliance can be used to control the temperature of the reaction chamber sections and the flow of fluid in the flow system.
  • port 16 A and 16 C are open while 16 B and 16 D are closed.
  • a pump 52 in the appliance delivers the sample fluid and, optionally, reagents required for PCR such as Taq polymerase, primers and nucleoside triphosphates, via port 16 A, through filter 24 , to reaction chamber section 22 A.
  • Port 16 A next is closed and 16 B is opened, and the pump 52 in the appliance is used to reciprocate fluid flow in cycles through flow channel 20 B between section 22 A, where polynucleotide dehybridization occurs, and section 22 B, where annealing and polymerization occurs.
  • Port 16 C can be used to vent the system, and also optionally to deliver Taq polymerase, nucleoside triphosphates, primers, and other reagents.
  • port 16 C is closed, port 16 D is opened, and the pump in the appliance is actuated to deliver the reaction products from PCR chamber sections 22 A and 22 B to detection chamber 22 C, which contains, e.g., a polynucleotide complementary to the amplified sense and/or antisense strand, immobilized on beads 92 .
  • Polymerization product is detected by observing the agglutination of beads 92 , e.g., visually through a translucent cover disposed over the detection region.
  • FIG. 11 Another embodiment is illustrated in FIG. 11 .
  • the function, structure, and operation of this device is identical to that shown in FIG. 10 , except that it comprises a single PCR reaction chamber 22 A.
  • the device is used in combination with an appliance such as appliance 50 shown in FIG. 3A .
  • the device includes means for heating and cooling reaction chamber 22 A alternatively to a temperature required for melting and a temperature required for annealing and polymerization.
  • the appliance is used to deliver a sample containing polymerase and other reagents required for PCR through inlet port 16 A to reaction chamber 22 A. Ports 16 A and 16 D are then closed using a valve connected in the appliance, while port 16 B and 16 C remain open.
  • the heating element in the appliance is then utilized to thermally cycle the reaction chamber between a temperature suitable for dehybridization and a temperature suitable for annealing and polymerization.
  • port 16 C is closed, port 16 D is opened and the sample is delivered to detection chamber 22 B which contains a polynucleotide probe, e.g., immobilized upon beads 92 .
  • a positive assay for the polynuucleotide is indicated by agglutination of the polynucleotide probe in the detection chamber.
  • a polymerase chain reaction is performed in the device illustrated schematically in FIG. 11 .
  • a sample cell lysate is added to a buffered solution of Taq polymerase, nucleoside triphosphates, polynucleotide primers and other reagents required for PCR.
  • the cell sample lysate is delivered via the appliance through entry port 16 A to PCR reaction chamber 22 A.
  • Ports 16 A and 16 D are closed by means of valves included in the appliance, while port 16 B and 16 C are open.
  • the microprocessor and temperature control element in the appliance are used to implement a temperature cycle in reaction chamber 22 A between 94° C., for polynucleotide dehybridization, and 65° C., for polymerase reaction.
  • port 16 C is closed, 16 D opened, and the pump in the appliance connected to port 16 B used to deliver the sample from.
  • the PCR reaction chamber 22 A through flow channel 20 B to the detection chamber 22 B.
  • Detection chamber 22 B contains beads 92 comprising a surface immobilized complementary polynucleotide capable of binding the amplified polynucleotide.
  • the agglutination of the beads caused by hybridization reaction between the amplified polynucleotide and the complementary polynucleotide is observed through a window disposed over the detection region 22 B, and provides a test for the presence of amplified polynucleotide product.
  • FIG. 12 depicts schematically a device 10 including substrate 14 used to separate a nucleic acid from a subpopulation of cells in a mixture in a biological fluid sample, and then to perform an assay for a particular nucleotide sequence.
  • Microfabricated on device 10 is a mesoscale flow path 20 which includes a cell separation chamber 22 A, a cell lysis chamber 22 B, a filter region 24 , a PCR reaction chamber comprising sections 22 C and 22 D, and a fractal detection region 40 .
  • the mesoscale flow system 20 is also provided with fluid entry/exit ports 16 A, 16 B, 16 C and 16 D.
  • the device is used in combination with an appliance, such as appliance 50 , shown in FIG. 6A .
  • valves in the appliance are used to close ports 16 C and 16 D, while ports 16 A and 16 B are open.
  • a sample containing a mixture of cells is. directed to the sample inlet port 16 A by the pump 52 in the appliance, and flows through the mesoscale flow path 20 to separation chamber 22 A.
  • Chamber 22 A contains binding moieties immobilized on the wall of the chamber which selectively bind to a surface molecule on a desired type of cell in the sample. Remaining cellular components exit the substrate via port 16 B.
  • flow with buffer is continued, to wash and assure isolation of the cell population.
  • port 6 B is closed and 16 C is opened. Flow is then increased sufficiently to dislodge the immobilized cells. Flow is continued, forcing cells through membrane piercing protrusions 90 in chamber 22 B, which tear open the cells releasing intracellular material.
  • Sample flow continues past filter 24 , which filters off large cellular membrane components and other debris, to mesoscale PCR chamber section 22 C, which is connected to PCR chamber section 22 D by flow channel 20 B.
  • Taq polymerase, primers and other reagents required for the PCR assay next are added to section 22 D through port 16 C from a mated port and flow path in the appliance, permitting mixing of the intracellular soluble components from the separated subpopulation of cells and the PCR reagents.
  • port 16 A With port 16 A closed, a pump in the appliance connected via port 16 B is used to cycle the PCR sample and reagents through flow channel 20 B between sections 22 C and 22 D, set at 94° C. and 65° C.
  • valves in the appliance next are used to close port 16 C and to open port 16 D.
  • the pump in the appliance connected to port 16 B is then used to direct the amplified polynucleotide isolated from the cell population to a detection region comprised of a fractally bifurcating series of flow paths 40 .
  • Flow restriction in the fractal region 40 serves as a. positive indicator of the presence of amplified polynucleotide product and is detected optically through a glass cover disposed over the detection region.

Abstract

Disclosed are devices for amplifying a preselected polynucleotide in a sample by conducting a polynucleotide polymerization reaction. The devices comprise a substrate microfabricated to define a sample inlet port and a mesoscale flow system, which extends from the inlet port. The mesoscale flow system includes a polynucleotide polymerization reaction chamber in fluid communication with the inlet port which is provided with reagents required for polymerization and amplification of a preselected polynucleotide. In one embodiment the devices may be utilized to implement a polymerase chain reaction (PCR) in the reaction chamber (PCR chamber). The PCR chamber is provided with the sample polynucleotide, polymerase, nucleoside triphosphates, primers and other reagents required for the polymerase chain reaction, and the device is provided with means for thermally controlling the temperature of the contents of the reaction chamber at a temperature controlled to dehybridize double stranded polynucleotide, to anneal the primers, and to polymerize and amplify the polynucleotide.

Description

    REFERENCE TO RELATED APPLICATIONS
  • This application is being filed contemporaneously with the following related copending applications: USSN MESOSCALE POLYNUCLEOTIDE AMPLIFICATION ANALYSIS [Attorney Docket No. UPA001 (8261/2)], Mesoscale Detection Structures; USSN [Attorney Docket No. UPA002 (8261/3)], Analysis Based on Flow Restriction; USSN [Attorney Docket No. UPA003 (8261/4)], Cell Handling in Mesoscale Analytical Devices; and U.S. Ser. No. ______ [Attorney Docket No. UPA005 (8261/6)], Mesoscale Sperm Handling Devices, the disclosures of which are incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • This invention relates generally to methods and apparatus for conducting analyses. More particularly, the invention relates to the design and construction of small, typically single-use, modules capable of analyses involving polymerase chain reaction (PCR).
  • In recent decades the art has developed a very large number of protocols, test kits, and cartridges for conducting analyses on biological samples for various diagnostic and monitoring purposes. Immunoassays, agglutination assays, and analyses based on polymerase chain reaction, various ligand-receptor interactions, and differential migration of species in a complex sample all have been used to determine the presence or concentration of various biological compounds or contaminants, or the presence of particular cell types.
  • Recently, small, disposable devices have been developed for handling biological samples and for conducting certain clinical tests. Shoji et al. reported the use of a miniature blood gas analyzer fabricated on a silicon wafer. Shoji et al., Sensors and Actuators, 15:101-107 (1988). Sato et al. reported a cell fusion technique using micromechanical silicon devices. Sato et al., Sensors and Actuators, A21-A23:948-953 (1990). Ciba Corning Diagnostics Corp. (USA) has manufactured a microprocessor-controlled laser photometer for detecting blood clotting.
  • Micromachining technology originated in the microelectronics industry. Angell et al., Scientific American , 248:44-55 (1983). Micromachining technology has enabled the manufacture of microengineered devices having structural elements with minimal dimensions ranging from tens of microns (the dimensions of biological cells) to nanometers (the dimensions of some biological macromolecules). This scale is referred to herein as “mesoscale”. Most experiments involving mesoscale structures have involved studies of micromechanics, i.e., mechanical motion and flow properties. The potential capability of mesoscale structures has not been exploited fully in the life sciences.
  • Brunette (Exper. Cell Res., 167:203-217 (1986) and 164:11-26 (1986)) studied the behavior of fibroblasts and epithelial cells in grooves in silicon, titanium-coated polymers and the like. McCartney et al. (Cancer Res., 41:3046-3051 (1981)) examined the behavior of tumor cells in grooved plastic substrates. LaCelle (Blood Cells, 12:179-189 (1986)) studied leukocyte and erythrocyte flow in microcapillaries to gain insight into microcirculation. Hung and Weissman reported a study of fluid dynamics in micromachined channels, but did not produce data associated with an analytic device. Hung et al., Med. and Biol. Engineering, 9:237-245 (1971); and Weissman et al., Am. Inst. Chem. Eng. J., 17:25-30 (1971). Columbus et al. utilized a sandwich composed of two orthogonally orientated v-grooved embossed sheets in the control of capillary flow of biological fluids to discrete ion-selective electrodes in an experimental multi-channel test device. Columbus et al., Clin. Chem., 33:1531-1537 (1987). Masuda et al. and Washizu et al. have reported the use of a fluid flow chamber for the manipulation of cells (e.g. cell fusion). Masuda et al., Proceedings IEEE/IAS Meeting, pp. 1549-1553 (1987); and Washizu et al., Proceedings IEEE/IAS Meeting pp. 1735-1740 (1988). The art has not fully explored the potential of using mesoscale devices for the analyses of biological fluids.
  • Methodologies for using polymerase chain reaction (PCR). to amplify a segment of DNA are well established. (See e.g., Maniatis et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, pp. 14.1-14.35.) A PCR amplification reaction can be performed on a DNA template using a thermostable DNA polymerase, e.g., Taq DNA polymerase (Chien et al. J. Bacteriol.:127:1550 (1976)), nucleoside triphosphates, and two oligonucleotides with different sequences, complementary to sequences that lie on opposite strands of the template DNA and which flank the segment of DNA that is to be amplified (“primers”). The reaction components are cycled between a higher temperature (e.g., 94° C.) for dehybridizing (“melting”) double stranded template DNA, followed by a lower temperature (e.g., 65° C.) for annealing and polymerization. A continual reaction cycle between dehybridization, annealing and polymerization temperatures provides exponential amplification of the template DNA. For example, up to 1 μg of target DNA up to 2 kb in length can be obtained from 30-35 cycles of amplification with only 10−6 μg of starting DNA. Machines for performing automated PCR chain reactions using a thermal cycler are available (Perkin Elmer Corp.)
  • PCR amplification has been applied to the diagnosis of genetic disorders (Engelke et al., Proc. Natl. Acad. Sci., 85:544 (1988), the detection of nucleic acid sequences of pathogenic organisms in clinical samples (Ou et al., Science, 239:295 (1988)), the genetic identification of forensic samples, e.g., sperm (Li et al., Nature, 335:414 (1988)), the analysis of mutations in activated oncogenes (Farr et al., Proc. Natl. Acad. Sci., 85:1629 (1988)) and in many aspects of molecular cloning (Oste, BioTechniques, 6:162 (1988)). PCR assays can be used in a wide range of applications such as the generation of specific sequences of cloned double-stranded DNA for use as probes, the generation of probes specific for uncloned genes by selective amplification of particular segments of cDNA, the generation of libraries of cDNA from small amounts of mRNA, the generation of large amounts of DNA for sequencing, and the analysis of mutations. There is a need for convenient rapid systems for PCR analyses, which could be used clinically in a wide range of potential applications in clinical tests such as tests for paternity, and genetic and infectious diseases.
  • An object of the invention is to provide analytical systems with optimal reaction environments that can analyze microvolumes of sample, detect very low concentrations of a polynucleotide, and produce analytical results rapidly. Another object is to provide easily mass produced, disposable, small (e.g., less than 1 cc in volume) devices having mesoscale functional elements capable of rapid, automated PCR analyses of a preselected cell or cell-free sample, in a range of applications. It is a further object of the invention to provide a family of such devices that individually can be used to implement a range of rapid clinical tests, e.g., tests for viral or bacterial infection, tests for cell culture contaminants, or tests for the presence of recombinant DNA or a gene in a cell, and the like.
  • SUMMARY OF THE INVENTION
  • The invention provides a family of small, mass produced, typically one-use devices for conducting a polynucleotide polymerization reaction to enable the rapid amplification of a polynucleotide in a sample. In one embodiment, the device comprises a solid substrate, on the order of a few millimeters thick and approximately 0.2 to 2.0 centimeters square, that is microfabricated to define a sample inlet port and a mesoscale flow system. The flow system of the device includes a sample flow channel extending from the inlet port, and a polynucleotide polymerization reaction chamber in fluid communication with the flow channel polynucleotide. The term “mesoscale” is used herein to define chambers and flow passages having a cross-sectional dimension on the order of 0.1 μm to 500 μm, with preferred reaction chamber widths on the order of 2.0 to 500 μm, more preferably 3-100 μm. For many applications, channels of 5-50 μm widths will be useful. Chambers in the substrate wherein amplification takes place may have somewhat larger dimensions, e.g., 1-5 mm. Preferred reaction chamber and channel depths are on the order of 0.1 to 100 μm, typically 2-50 μm. The flow channels in the devices, leading to the reaction chambers, have preferred widths on the order of 2.0 to 200 μm and depths on the order of 0.1 to 100 μm.
  • In one embodiment, the devices may be utilized to implement a polymerization chain reaction (PCR) in the reaction chamber. The reaction chamber may be provided with reagents for PCR including a sample polynucleotide, polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence that is complementary to the sample polynucleotide, wherein the first and second primers define the termini of the polymerized polynucleotide product. The device also may include means for thermally cycling the contents of the PCR chamber, such that, in each cycle, the temperature is controlled to 1) dehybridize (“melt”) double stranded polynucleotide, 2) anneal the primers to single stranded polynucleotide, and 3) synthesize amplified polynucleotide between the primers. In one embodiment, the PCR chamber may comprise one section which is thermally cycled sequentially to the required temperatures for PCR. Alternatively, the PCR chamber may comprise two or more sections, set at the different temperatures required for dehybridization, annealing and polymerization, in which case the device further comprises means for cycling the contents of the chamber between the sections to implement the PCR, e.g., a pump or other means as disclosed herein. The device may further include means for detecting the amplified polynucleotide. The devices may be used to implement a variety of automated, sensitive and rapid polynucletide analyses, including analyses for the presence of polynucleotides in cells or in solution, or for analyses for a virus or cell types using the presence of a particular polynucleotide as a marker.
  • Generally, as disclosed herein, the solid substrate comprises a chip, containing the mesoscale flow system and the reaction chamber(s). The mesoscale flow channels and reaction chambers may be designed and fabricated from silicon and other solid substrates using established micromachining methods. The mesoscale flow systems in the devices may be constructed by microfabricating flow channels and one or more reaction chambers into the surface of the substrate, and then adhering a cover, e.g., a transparent glass cover, over the surface. The devices analyze microvolumes (<10 μL) of a sample, introduced into the flow system through an inlet port defined, e.g., by a hole communicating through the substrate or the cover. The volume of the mesoscale flow system typically will be <5 μL, and the volume of individual channels, chambers, or other functional elements are often less than 1 μL, e.g., in the nanoliter or even picoliter range. Polynucleotides present in very low concentrations, (e.g. nanogram quantities) can be rapidly amplified (<10 minutes) and detected. After a polynucleotide polymerization assay is complete, the devices may be discarded.
  • The chips typically will be used with an appliance which contains a nesting site for holding the chip, and which mates one or more input ports on the chip with one or more flow lines in the appliance. After a biological fluid sample suspected. to contain a particular polynucleotide is applied to the inlet port of the substrate, the chip is placed in the appliance and a pump, e.g., in the appliance, is actuated to force the sample through the flow system. Alternatively, a sample may be injected into the chip by the appliance. Reagents required for the assay, such as a polymerase, may be added to the polynucleotide sample prior to injection into the chip. Alternatively, reagents necessary to complete the assay can be injected into the reaction chamber from a separate inlet port, e.g., by the appliance. Fluid samples and reagents may also enter the mesoscale flow system by capillary action.
  • In one embodiment, the devices may be utilized to perform a PCR assay, and the temperature of one or more section(s) in the reaction chamber can be regulated by, e.g., providing one or more electrical resistance heaters in the substrate near the reaction chamber, or by using a pulsed laser or other source of electromagnetic energy directed to the reaction chamber. The appliance may include electrical contacts in the nesting region which mate with contacts integrated into the structure of the chip, e.g., to power electrical resistance heating of the reaction chamber. A cooling element may also be provided in the appliance to assist in the thermal regulation of the reaction chamber. The appliance may be provided with conventional circuitry sensors in communication with sensors in the device for thermally regulating the PCR temperature cycles required for the dehybridization and polymerization reactions.
  • The amplified polynucleotide produced by the polynucleotide amplification reaction in the mesoscale reaction chamber can be collected through a port in the substrate and detected, e.g., by gel electrophoresis or any other method. Alternatively, a mesoscale detection region may be microfabricated in the substrate, in fluid communication with the reaction chamber in the device, as a part of the mesoscale flow system. The detection region may include a labeled binding moiety, such as a labeled polynucleotide or antibody probe, capable of detectably binding with the amplified polynucleotide. The presence of polymerized polynucleotide product in the detection region can be detected, e.g., by optical detection of agglutination of the polymerized polynucleotide and the binding moiety through a glass cover over the detection region or through a translucent section of the substrate itself.
  • A positive assay may also be indicated by detectable changes in sample fluid flow properties such as changes in pressure or electrical conductivity at different points in the flow system upon production of polymerized polynucleotide in the reaction chamber. In one embodiment, the device comprises a mesoscale flow system which includes a polynucleotide amplification reaction chamber, and a detection region is used in combination with an appliance which includes sensing equipment such as a spectrophotometer capable of reading a positive result through an optical window, e.g., disposed over the detection region. The appliance may also be designed to receive electrical signals indicative of a pressure reading, conductivity, or the like, sensed in the reaction chamber, the detection region, or some other region of the flow system.
  • The substrate may comprise a plurality of detection/reaction chambers to enable the rapid parallel detection of polynucleotides in a mixture. The mesoscale flow system may include protrusions, or a section of reduced cross sectional area, to enable the lysis of cells in the microsample prior to delivery to the reaction chamber. Sharp edged pieces of silicon, trapped in the flow path, can also be used as a lysis means. The mesoscale flow system also may include a cell capture region comprising a binding moiety, e.g., immobilized on a wall of a flow channel, which binds a particular type of cell in a heterogeneous cell population at a low fluid flow rate, and at a greater flow rate, releases the cell type prior to delivery of the cells to a cell lysis region then to a reaction chamber. In this embodiment, intracellular DNA or RNA is isolated from a selected cell subpopulation and delivered to the mesoscale reaction chamber for polynucleotide analysis in one device.
  • In another embodiment, magnetic beads may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance. In one embodiment, a polynucleotide probe may be immobilized on the magnetic beads enabling the beads to bind to amplified polynucleotide in the reaction chamber. Magnetic beads containing an immobilized polynucleotide probe may be, e.g., transported through the flow system to the reaction chamber at the end of an assay to bind to the polymerized polynucleotide product. The bound polynucleotide may then be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port.
  • Some of the features and benefits of the devices are illustrated in Table 1. The devices can provide a rapid test for the detection of pathogenic bacteria or viruses, or for the presence of certain cell types, or the presence of a gene or a recombinant DNA sequence in a cell. The devices as disclosed herein are all characterized by a mesoscale flow system including a PCR chamber which is used to amplify a polynucleotide in a sample, which may be provided with polymerase and other reagents required for PCR. The device may be used to amplify a polynucleotide in a wide range of applications. At the conclusion of the assay the chip typically is discarded.
    TABLE 1
    Feature Benefit
    Flexibility No limits to the number of chip
    designs or applications available.
    Reproducible Allows reliable, standardized, mass
    production of chips.
    Low Cost Allows competitive pricing with
    Production existing systems. Disposable nature
    for single-use processes.
    Small Size No bulky instrumentation required.
    Lends itself to portable units and
    systems designed for use in non-
    conventional lab environments.
    Minimal storage and shipping costs.
    Microscale Minimal sample and reagent volumes
    required. Reduces reagent costs,
    especially for more expensive,
    specialized test procedures. Allows
    simplified instrumentation schemes.
    Sterility Chips can be sterilized for use in
    microbiological assays and other
    procedures requiring clean
    environments.
    Sealed System Minimizes biohazards. Ensures
    process integrity.
    Multiple Circuit Can perform multiple processes or
    Capabilities analyses on a single chip. Allows
    panel assays.
    Multiple Expands capabilities for assay and
    Detector process monitoring to virtually any
    Capabilities system. Allows broad range of
    applications.
    Reuseable Chips Reduces per process cost to the user
    for certain applications.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic longitudinal cross sectional view of a device according to the invention that includes a solid substrate 14, on which is machined mesoscale flow channel 20 connected to inlet ports 16 and PCR reaction chamber 22, with a transparent cover 12 adhered to the surface of the substrate.
  • FIG. 2 is a perspective view of the device of FIG. 1.
  • FIG. 3A is a schematic illustration of an analytical device 10 nested within a schematically illustrated appliance 50, which may be used to support the device 10 and which includes heating element 57 for regulating the temperature of the reaction chamber 22 in device 10.
  • FIG. 3B is a schematic illustration of an analytical device 10 nested within appliance 50, which may be used to support the device 10 and which includes the heating element 53 for regulating the temperature of the reaction chamber 22 in device 10.
  • FIG. 4 is a schematic longitudinal cross sectional view of a device according to the invention that includes a solid substrate 14, on which is machined mesoscale flow channel 20 connected to inlet ports 16 and PCR reaction chamber sections 22, with a transparent cover 12 adhered to the surface of the substrate.
  • FIG. 5 is a perspective view of the device of FIG. 4.
  • FIG. 6A is a schematic illustration of analytical device 10 nested within appliance 50, which may be used to support the device 10, and which includes heating elements 57 for regulating the temperature of the reaction chamber sections 22 in device 10.
  • FIG. 6B is a schematic illustration of analytical device 10 nested within appliance 50, which may be used to support the device 10 and which includes heating element 57 for regulating the temperature of the reaction chamber section 22A in device 10.
  • FIG. 7 is a schematic plan view of a substrate 14 microfabricated with mesoscale PCR chamber sections 22A and 22B, in fluid communication with a detection chamber. comprised of a fractally bifurcating system of flow channels 40 symmetrically disposed on the substrate.
  • FIG. 8 is a cross sectional perspective view of a flow channel 20 in substrate 14 with cell or debris filtering protrusions 80 extending from a wall of the channel.
  • FIG. 9 is a cross sectional perspective view of a flow channel 20 in substrate 14 with cell piercing protrusions 90 extending from a wall of the channel.
  • FIG. 10 is a schematic plan view of a mesoscale PCR analytical device including PCR chamber sections 22A and 22B microfabricated in the silicon substrate 14.
  • FIG. 11 is a schematic plan view of another mesoscale PCR analytical device including a PCR chamber 22A microfabricated in the silicon substrate 14.
  • FIG. 12 is a schematic plan view of an analytical device fabricated with a series of mesoscale chambers suitable for implementing a variety of functions including cell sorting, cell lysing and PCR analysis.
  • FIG. 13 is a schematic plan view of an analytical device fabricated with a pair of fractally bifurcating flow channels 40.
  • FIGS. 14, 15 and 16 illustrate top plan views of different embodiments of a mesoscale filter 24 microfabricated in flow channel 20 in an analytical device 10.
  • FIG. 17 is a schematic perspective view of an apparatus 60 used in combination with device 10 for viewing the contents of device 10.
  • FIG. 18 is a schematic cross sectional view of the apparatus 60 of FIG. 17.
  • Like reference characters in the respective drawn figures indicate corresponding parts.
  • DETAILED DESCRIPTION
  • The invention provides a family of small, mass produced, typically one-use devices for conducting a polynucleotide polymerization reaction to enable the rapid amplification of a polynucleotide in a fluid sample. The devices comprise a solid substrate, typically on the order of a few millimeters thick and approximately 0.2 to 2.0 centimeters square, microfabricated to define a sample inlet port and a mesoscale flow system. The mesoscale flow system includes at least one sample flow channel extending from the inlet port and at least one polynucleotide polymerization reaction chamber in fluid communication with the flow channel. The arrangement of channels, chambers, and multiple ports facilitates the sequential, properly timed, and volumetrically correct addition of sample and reagents within the device. The reaction chamber and the flow channels preferably have a mesoscale dimension, i.e. a cross sectional dimension on the order of 0.1 to 500 μm. The preferred depth of the reaction chamber is on the order of 0.7 to 100 μm, and preferred width- is on the order of 2.0 to 500 μm. The preferred depth of the flow channels is on the order of 0.1 to 100 μm, and the preferred. width is on the order of 2.0 to 200 μm.
  • In one embodiment, the devices may be utilized to conduct a polymerase chain reaction (PCR) in the reaction chamber (PCR chamber). The PCR chamber is provided with reagents required for a polymerase chain reaction including the sample polynucleotide, a polymerase such as Taq polymerase, nucleoside triphosphates, a first primer hybridizable with the sample polynucleotide, and a second primer hybridizable with a sequence complementary to the polynucleotide, wherein the first and second primers define the termini of the polymerized product polynucleotide. The polymerase chain reaction may be performed, according to methods established in the art (Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989). The device may include means for thermally cycling the contents of the chamber such that, in each cycle, temperature is controlled to dehybridize double stranded polynucleotide to produce single stranded polynucleotide, and then to anneal the primers and allow polynucleotide polymerization. In addition, other polynucleotide. polymerization reactions known in the art may be utilized including the isothermal in vitro amplication of DNA by a restriction enzyme/DNA polymerase system. Walker etal., Proc. Natl. Acad. Sci U.S.A., 89:392-396 (1992). A ligase chain reaction also may be utilized. Backman, K. Clin. Chem., 38:457-458 (1992).
  • In one embodiment, the device also may include means for detecting the amplified polynucleotide. The devices may be used to implement a variety of automated, sensitive and rapid polynucleotide analyses including the analysis of polynucleotides in cells or in solution. At the conclusion of the assay the devices typically are discarded. The use of disposable devices eliminates contamination among samples. The sample and reaction mixture at all times can remain entombed, and the low volume simplifies waste disposal.
  • Analytical devices having mesoscale flow channels and reaction chambers can be designed and fabricated in large quantities from a solid substrate material. They can be sterilized easily. Silicon is preferred because of the well-developed technology permitting its precise and efficient fabrication, but other materials may be used, such as polymers including polytetrafluoro-ethylenes. The sample inlet and other ports, the mesoscale flow system, including the sample flow channel(s) and the reaction chamber(s) and other functional elements, thus may be fabricated in expensively in large quantities from a silicon substrate by any of a variety of micromachining methods known to those skilled in the art. The micromachining methods available include film deposition processes such as spin coating and chemical vapor deposition, laser fabrication or photolithographic techniques such as UV or X-ray processes, or etching methods which may be performed by either wet chemical processes or plasma processes. (See, e.g., Manz et al., Trends in Analytical Chemistry 10: 144-149 (1991)).
  • Flow channels of varying widths and depths can be fabricated with mesoscale dimensions. The silicon substrate containing a fabricated mesoscale flow channel may be covered and sealed with a thin anodically bonded glass cover. Other clear or opaque cover materials may be used. Alternatively, two silicon substrates can be sandwiched, or a silicon substrate can be sandwiched between two glass covers. The use of a transparent cover results in a window which facilitates dynamic viewing of contents in the mesoscale flow system. Other fabrication approaches may be used.
  • In one embodiment, a PCR analysis may be conducted in the reaction chamber of the devices. As illustrated schematically in FIGS. 1 and 2, the device 10 may include a silicon substrate 14 microfabricated with inlet ports 16, a mesoscale flow channel 20, and PCR chamber 22. The polynucleotide sample and the reagents required for the polymerization reaction are added, and the products withdrawn (if necessary) through flow channel 20 and reaction chamber 22 through inlet ports 16 which are fabricated on either end of the flow channel 20. The substrate 14 is covered with a glass or plastic coverslip 12. During an analysis, the device 10 may be used in combination with an appliance, such as appliance 50 shown schematically in FIG. 3A. Appliance 50 includes a nesting site 58 for holding the device 10, and for registering ports, e.g., ports 16 on device 10, with a flow line 56 in the appliance. A pump 52 in appliance 50 is used to deliver a sample and/or reagents from flow line 56 in the appliance to the reaction chamber 22 via the inlet ports 16.
  • The appliance 50 may include a heating/cooling element 57 for controlling the temperature within the PCR chamber, e.g., an electrical heating element and/or a refrigeration coil. The electrical heating element may alternatively be integrated into the substrate 10, with contacts for power mated to matching electrical contacts in the appliance below the reaction chamber 22. Alternatively, as shown in FIG. 3B, the appliance may include a heating means 53, such as a laser, or other source of electromagnetic energy, disposed over the reaction chamber in device 10. Alternatively, the laser may be disposed in the appliance below the reaction chamber. A microprocessor in the appliance may be used to regulate the heating element in order to provide a temperature cycle in the PCR chamber between a temperature suitable for dehybridization, e.g. 94° C., and a temperature suitable for annealing and polymerization, e.g. 65° C.. A thermocouple may also be provided in the substrate in electrical contact with the appliance, to allow the microprocessor to detect and maintain the temperature cycles in the reaction chamber. A cooling element, such as a miniature thermoelectric heat pump (Materials Electronic Products Corporation, Trenton, New Jersey), may also be included in the appliance for adjusting the temperature of the reaction chamber. In another embodiment, in the appliance shown in FIG. 3B, the temperature of the reaction chamber can be regulated by a timed laser pulse directed at the reaction chamber through glass cover 12, so as to allow sequential heating and cooling of the sample to the required temperatures for the PCR cycle. The thermal properties of silicon enable a rapid heating and cooling cycle.
  • The analytical devices also may be utilized in combination with an appliance for viewing the contents of the mesoscale channels in the devices. The appliance in one embodiment may comprise a microscope for viewing the contents of the mesoscale channels in the devices. In another embodiment, a camera may be included in the appliance, as illustrated in the appliance 60 shown schematically in FIGS. 17 and 18. The appliance 60 is provided with a housing 62, a viewing screen 64 and a slot 66 for inserting a chip into the appliance. As shown in cross section in FIG. 17, the appliance 60 also includes a video camera 68, an optical system 70, and a tilt mechanism 72 for holding device 10, and allowing the placement and angle of device 10 to be adjusted manually. The optical system 70 may include a lens system for magnifying the channel contents, as well as a light source. The video camera 68 and screen 64 allow changes in sample fluid properties, such as flow properties or color, induced by the presence of polymerized polynucleotide, to be monitored visually and optionally recorded using the appliance.
  • In another embodiment, illustrated schematically in FIGS. 4, 5 and 6A, a mesoscale PCR chamber may be microfabricated with multiple sections, e.g., two sections 22A and 22B, connected by flow channel 20B. In this embodiment, section 22A is heated to a temperature suitable for dehybridization and section 22B is heated to a temperature suitable for annealing and polymerization. During an analysis, the device 10 may be placed in appliance 50 (FIG. 6A). The appliance 50 is provided with means 57 for controlling the temperature of the reaction chamber sections. Alternatively, a laser may be used to heat the sections. A thermocouple can be included in the substrate to monitor the temperatures of the sections of the reaction chamber, and its output may be used to control thermal input with the aid of a microprocessor. In operation, a pump 52 in the appliance is used to deliver the polynucleotide sample and the required PCR reagents from flow line 56 through inlet port 16A to section 22A. The pump 52, which also may be controlled by a microprocessor in the appliance, is then used to cycle the sample continually between sections 22A and 22B, through channel 20B to implement a continual polymerase chain reaction cycle, while port 16B serves as a vent. When the reaction is complete, the pump 52 in appliance 50 may be used to deliver the sample through port 16B and line 56 in the appliance to port 59 to recover the product. Of course, three or more chambers may be used, each of which are maintained at a temperature suitable for conducting a particular reaction.
  • In another embodiment, in the device 10 shown in FIGS. 4, 5 and 6B, a heating element may be used to heat section 22A to a temperature suitable for dehybridization of double stranded DNA, e.g. 94° C., while section 22B and channel 20B, which connects sections 22A and 22B, are spaced apart from section 22A such that upon transport of a heated sample from section 22A to section 22B, heat is dissipated sufficiently to permit the temperature of the sample to fall to the temperature required for annealing and polymerization before the sample is returned to section 22A for further cycling. This may be achieved readily as silicon has a relatively high thermal conductivity and the area of interface between the liquid sample and the substrate is quite high. In this embodiment, microprocessors in the appliance 50 are used to control pump 52, which regulates the flow cycle of the sample between sections 22A and 22B. Thus, a dynamic thermal equilibrium creates a temperature gradient along the flow path between the chambers, and appropriate temperatures are achieved in both using a single heating source. Other designs are possible. For example, the annealing and polymerization reactions could be implemented in different sections of a single PCR chamber, set at different optimized temperatures.
  • The polymerase chain reaction may be implemented using any thermostable polynucleotide polymerase, such as Taq polymerase. Reagents such as Taq polymerase may be added to a sample and then delivered through an inlet port to the mesoscale reaction chamber, or the reagents may be delivered to the reaction chamber independently of the sample through a separate inlet port.
  • The capacity of the devices is very small and therefore the amount of sample fluid required for an analysis is low. For example, in a 1 cm×1 cm silicon substrate, having on its surface an array of 500 grooves which are 10 microns wide×10 microns deep×1 cm (104 microns) long, the volume of each groove is 10−3 μL and the total volume of the 500 grooves is 0.5 μL. The low volume of the mesoscale flow systems allows assays to be performed on very small amounts of a liquid sample (<5 μL). The mesoscale flow systems of the devices may be microfabricated with microliter volumes, or alternatively nanoliter volumes or less, which advantageously limits the amount of sample and/or reagent fluids required for an assay.
  • The devices of the invention provide mesoscale polynucleotide polymerization reaction chambers which may be used for the rapid amplification of a polynucleotide in a biological fluid sample. The device may also include a means for detecting the amplified polynucleotide product disposed either in the substrate or in the appliance. The presence of amplified polynucleotide product in the device can be detected by any of a number of methods including monitoring the pressure or electrical conductivity of sample fluids entering and/or exiting the reaction chamber in the mesoscale flow system. The presence of amplified polynucleotide product also can be detected by a binding assay with a labeled probe such as a labeled oligonucleotide or antibody probe, or by gel electrophoresis.
  • In one embodiment, the amplified polynucleotide product can be detected by using a detection chamber fabricated in the mesoscale flow system in the substrate in fluid communication with the reaction chamber. The detection chamber is provided with a binding moiety capable of binding to the amplified polynucleotide. The binding moiety may comprise, e.g., a polynucleotide or antibody probe. The detection chamber may be fabricated in accordance with methods disclosed in U.S. Ser. No. ______ [Attorney Docket No. UPA001 (8261/2)], Mesoscale Detection Structures, the disclosure of which is incorporated herein by reference. The device may be used in combination with an appliance containing a microprocessor for detecting and recording data obtained during an assay.
  • In one embodiment, the mesoscale detection chamber may be provided with an inert substrate, e.g., a bead or other particle, capable of binding to the polymerized polynucleotide, to cause detectable agglomeration of the beads in the presence of polymerized polynucleotide product. Particle induced agglomeration can be enhanced by the attachment of a binding moiety, such as an antibody, to the particle.
  • Antibodies or other binding moieties capable of binding to the polymerized polynucleotide may be introduced into the detection chamber, or may be coated, either chemically or by absorption, onto the surface of the detection region, or alternatively, onto the surface of an inert particle in the detection region, to induce binding, giving a positive test for the polynucleotide. Techniques for the chemical activation of silaceous surfaces are well developed, particularly in the context of chromatography. (See, e.g., Haller in: Solid Phase Biochemistry, W. H. Scouten, Ed., John Wiley, New York, pp 535-597 (1983); and Mandenius et al., Anal. Biochem. 170: 68-72 (1988)). In one embodiment, the binding moiety may comprise an antibody, and immunoassay techniques known in the art can be performed in the detection region. (See, e.g., Bolton et al., Handbook of Experimental Immunology, Weir D.M., Ed., Blackwell Scientific Publications, Oxford, 1986, Vol. 1, Chapter 26, for a general discussion of immunoassays).
  • An optically detectable label such as a fluorescent molecule or fluorescent bead may be attached to the binding moiety to enhance detection of the polymerized polynucleotide. Alternatively a second labeled substance, such as a fluorescent labeled antibody may be delivered through the flow system to bind to the bound polynucleotide/binding moiety complex in the detection region to produce a “sandwich” including an optically detectable moiety indicative of the presence of the analyte. The binding of the amplified polynucleotide to the binding moiety in the detection region may be detected, e.g., optically, either visually or by machine, through a transparent window disposed over the detection region. In one embodiment, the production of amplified polynucleotide may be detected by the addition of a dye such as ethidium bromide, which exhibits enhanced fluorescence upon binding to double stranded polynucleotide. Higuchi et al., Biotechnology, 10: 413 (1992).
  • The detection chamber may also be provided with a labelled complementary polynucleotide capable of binding to one of the strands of the amplified polynucleotide, e.g., a labeled polynucleotide immobilized on a bead, to enable the detection of polymerized polynucleotide product by means of bead agglutination. Polynucleotide. hybridization techniques known in the art may be utilized. Maniatis et al., Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Press, 1989); Vener et al., Anal. Chem., 198:308-311 (1991). Polynucleotide probes may be attached to, e.g., a submicron latex particle. Wolf et al., Nucleic Acids Research, 15:2911-2926 (1987).
  • Polynucleotide polymerization also can be detected using a detection region sensitive to flow restriction caused by the presence of polymerized polynucleotide produced in the reaction chamber, as is disclosed in USSN [Attorney Docket No. UPA002 (8261/3)], Analysis Based on Flow Restriction, the disclosure of which is incorporated herein by reference. The presence of amplified polynucleotide also may be detected by sensing the pressure or electrical conductivity of the fluid samples entering and exiting the flow system. The conductivity may be measured, e.g., using electrical contacts which extend through the substrate and which mate with electrical contacts in an appliance used in combination with the device. Electrical contacts can be fabricated by known techniques of thermal gradient zone melting. (See Zemel et al., in: Fundamentals and Applications of Chemical Sensors, D. Schuetzle and R. Hammerle, Eds., ACS Symposium Series 309, Washington, D.C., 1986, p. 2.)
  • Amplified polynucleotide in the reaction chamber can be detected by monitoring the pressure of-the sample fluids. For example, in a device 10, nested in appliance 50, illustrated schematically in FIG. 6A, the pressure detectors 54 connected to sample fluid entering and exiting the mesoscale flow system through ports 16 will allow the detection of pressure decreases caused by the presence of polymerized product and resulting clogging or flow restriction. A mesoscale pressure sensor also may be fabricated directly on the silicon substrate. Angell et al., Scientific American 248: 44-55 (1983).
  • Polynucleotide polymerization can be detected by the use of a mesoscale flow system sensitive to flow restriction, constructed with a “fractal” pattern, i.e., a pattern of serially bifurcating flow channels. The fractally bifurcating channels may be fabricated on a silicon substrate with reduced dimensions at each bifurcation, providing sequentially narrower flow channels. FIG. 7 shows a schematic plan view of a substrate 14 fabricated with a fractally bifurcating system of flow channels 40 connected via channel 20 to ports 16 and a PCR reaction chamber comprising sections 22A and 22B. The presence of amplified polynucleotide product in a sample will influence the flow characteristics within the fractal. The channels 40 in this embodiment are symmetrically disposed and have a sequentially narrower diameter towards the center of the fractal. Flow through this fractal is sensitive to changes in fluid viscosity caused by the presence of polymerized product. Alternatively a more complex fractal flow system may be utilized, as illustrated in FIG. 13. FIG. 13 illustrates a pair of fractally bifurcating flow channels.40A and 40B. The fractal flow channel 40A is constructed with sequentially narrower flow channels towards the center of the fractal, resulting in an enhanced sensitivity to flow restriction.
  • Flow restriction in the fractal region can be detected, e.g., optically, through a transparent cover over the detection region. Alternatively, one or more pressure sensors may be utilized to detect pressure. changes due to changes in fluid properties caused by the presence of amplified polynucleotide in or beyond the fractal flow paths. Changes in conductivity upon polynucleotide production also may be readily detected through electrical conductivity sensors in contact with the flow region. For example, clogging of the fractal region 40 which blocks flow from inlet port 16A to outlet port 16B could be detected by a conventional conductivity probe 17 whose output is indicative of the presence or absence of aqueous fluid in the outflow channel. Binding moieties such as labeled antibodies or polynucleotide probes may be included in the fractal region, e.g. immobilized, or on a solid phase reactant such as a bead, to bind to the product polynucleotide to induce flow restriction in the fractal flow path.
  • In one embodiment, the mesoscale flow system includes a chamber for lysing cells from a sample in preparation for downstream polynucleotide analysis. The devices also may include a region adapted to separate a particular type of cell in a heterogeneous cell population. The cell separation region includes immobilized binding moieties immobilized on structures within the substrate which selectively reversibly bind a target cell via a characteristic cell surface molecule such as a protein. Other cells in the sample pass downstream and are discarded into a sump or through an exit port. Flow may be continued to wash the cells, e.g., with a flow of buffer. At higher flow rates and pressures, the washed cells are sheared from the surfaces, released from the separation region, and move downstream to a lysis means, which lyse the cells prior to PCR analysis of an intracellular RNA or DNA molecule.
  • The cell lysing means typically is disposed in the flow path between the cell separation region (if any) and the polynucleotide polymerization reaction chamber to allow the cells to be lysed prior to analysis for an intracellular polynucleotide. As illustrated in FIG. 9, the cell lysing means may comprise cell membrane piercing protrusions 90 extending from a surface of a flow channel 20. As fluid flow is forced through the piercing protrusion 90, cells are ruptured. In another embodiment, the cell lysis means may simply comprise a region of restricted cross-sectional dimension which implements cell lysis upon application of sufficient flow pressure. The cell lysis means may also comprise sharp edged pieces of silicon trapped within a mesoscale lysis chamber. An appliance which includes means, such as a pump, for forcing the cell containing sample into the cell lysis means, causes cell lysis upon application of sufficient flow pressure, and subsequently delivers the sample through the flow system to the reaction chamber. In another embodiment, the cell lysis means may comprise a cell lysing agent. Cell lysing agents known in the art may be utilized.
  • Reagents may be added to the reaction chamber from a separate inlet port in the substrate in fluid communication with the reaction chamber. A filter, microfabricated in the flow channel on the silicon substrate, can be used to filter cell debris prior to polynucleotide analysis. In one embodiment, shown in FIGS. 14, 15 and 16, the filter 24 in device 10 may comprise a mesoscale flow channel of reduced diameter in comparison with channel 20. In operation, sample flows from sample flow channel 20A through filter 24. Sample filtrate then exits filter 24 and flows through channel 20B. The filter 24 is microfabricated with depths and widths on the order of 0-1 to 20 μm, while flow channels 20A and 20B have maximum depths and widths on the order of approximately 500 μm. As illustrated in FIG. 8, the surface of a flow channel 20 may also include protrusions 80 constituting a cellular sieve for separating cells by size upstream from the PCR analysis chamber. As cell samples are flowed through the flow channel, typically under low pressure, only cells small enough to pass between the protrusions 80 reach downstream functional elements. These cells subsequently can be delivered through a cell lysis region, then to a PCR reaction chamber for analysis.
  • In another embodiment, paramagnetic or ferromagnetic beads may be provided within the mesoscale flow system, which can be moved along the flow system by an external magnetic field, e.g., in the appliance. The beads may be used to transport reagents between functional elements in the device, or to displace a sample, a reagent or a reaction mixture. In one embodiment, a polynucleotide probe may be immobilized on the magnetic beads enabling the beads to bind to amplified polynucleotide. Magnetic beads comprising a coating of polynucleotide probe may be transported through the flow system to the reaction chamber at the end of an assay to bind to the polymerized polynucleotide product. The bound polymerized polynucleotide then may be transported on the magnetic beads to a detection or purification chamber in the flow system, or to a collection port.
  • One embodiment of the invention, illustrated in FIG. 10, is a device 10 comprising a substrate 14 microfabricated with a mesoscale PCR chamber comprising sections 22A and 22B, which are connected by flow path 20B. The PCR chip 10 is used in combination with an appliance, such as appliance 50, shown in FIG. 6A, which contains a nesting site for holding the chip. The appliance SO is provided with flow paths 56 mated to ports 16A, 16B, 16C and 16D in device 10. The appliance also includes valves that allow the ports 16A, 16B, 16C and 16D to be mechanically opened and closed. In one embodiment, the flow systems of the devices may be maintained at a hydraulically full volume, and valves in the appliance, or alternatively, in the devices, may be utilized to direct fluid flow. Sections 22A and 22B of the PCR chamber are heated to 94° C. and 65° C., respectively, to provide a melting temperature and an annealing temperature as required for PCR. As discussed above, reaction chamber sections maybe heated by means of an electrical contact-integrated in the substrate below the sections, which can mate with electrical contacts in the appliance. Alternatively, an optical laser may be used to heat the reaction chamber sections through a glass cover disposed over the substrate. A heat sensor may be provided in the substrate, in electrical contact with the appliance. A microprocessor in the appliance can be used to control the temperature of the reaction chamber sections and the flow of fluid in the flow system.
  • In operation, initially, with the channels and chambers full of buffer, port 16A and 16C are open while 16B and 16D are closed. A pump 52 in the appliance delivers the sample fluid and, optionally, reagents required for PCR such as Taq polymerase, primers and nucleoside triphosphates, via port 16A, through filter 24, to reaction chamber section 22A. Port 16A next is closed and 16B is opened, and the pump 52 in the appliance is used to reciprocate fluid flow in cycles through flow channel 20B between section 22A, where polynucleotide dehybridization occurs, and section 22B, where annealing and polymerization occurs. Port 16C can be used to vent the system, and also optionally to deliver Taq polymerase, nucleoside triphosphates, primers, and other reagents. When the polymerase cycling reaction is complete, e.g., after 30-35 cycles, port 16C is closed, port 16D is opened, and the pump in the appliance is actuated to deliver the reaction products from PCR chamber sections 22A and 22B to detection chamber 22C, which contains, e.g., a polynucleotide complementary to the amplified sense and/or antisense strand, immobilized on beads 92. Polymerization product is detected by observing the agglutination of beads 92, e.g., visually through a translucent cover disposed over the detection region.
  • Another embodiment is illustrated in FIG. 11. The function, structure, and operation of this device is identical to that shown in FIG. 10, except that it comprises a single PCR reaction chamber 22A. The device is used in combination with an appliance such as appliance 50 shown in FIG. 3A. The device includes means for heating and cooling reaction chamber 22A alternatively to a temperature required for melting and a temperature required for annealing and polymerization.
  • In operation, the appliance is used to deliver a sample containing polymerase and other reagents required for PCR through inlet port 16A to reaction chamber 22A. Ports 16A and 16D are then closed using a valve connected in the appliance, while port 16B and 16C remain open. The heating element in the appliance is then utilized to thermally cycle the reaction chamber between a temperature suitable for dehybridization and a temperature suitable for annealing and polymerization. When the PCR reaction cycle is complete, port 16C is closed, port 16D is opened and the sample is delivered to detection chamber 22B which contains a polynucleotide probe, e.g., immobilized upon beads 92. A positive assay for the polynuucleotide is indicated by agglutination of the polynucleotide probe in the detection chamber.
  • The invention will be understood further from the following, nonlimiting examples.
  • EXAMPLE 1
  • A polymerase chain reaction is performed in the device illustrated schematically in FIG. 11. To perform a PCR analysis to detect a polynucleotide in a cell, a sample cell lysate is added to a buffered solution of Taq polymerase, nucleoside triphosphates, polynucleotide primers and other reagents required for PCR. The cell sample lysate is delivered via the appliance through entry port 16A to PCR reaction chamber 22A. Ports 16A and 16D are closed by means of valves included in the appliance, while port 16B and 16C are open. The microprocessor and temperature control element in the appliance are used to implement a temperature cycle in reaction chamber 22A between 94° C., for polynucleotide dehybridization, and 65° C., for polymerase reaction. After the polymerase chain reaction is complete, port 16C is closed, 16D opened, and the pump in the appliance connected to port 16B used to deliver the sample from. the PCR reaction chamber 22A through flow channel 20B to the detection chamber 22B. Detection chamber 22B contains beads 92 comprising a surface immobilized complementary polynucleotide capable of binding the amplified polynucleotide. The agglutination of the beads caused by hybridization reaction between the amplified polynucleotide and the complementary polynucleotide is observed through a window disposed over the detection region 22B, and provides a test for the presence of amplified polynucleotide product.
  • EXAMPLE 2
  • FIG. 12 depicts schematically a device 10 including substrate 14 used to separate a nucleic acid from a subpopulation of cells in a mixture in a biological fluid sample, and then to perform an assay for a particular nucleotide sequence. Microfabricated on device 10 is a mesoscale flow path 20 which includes a cell separation chamber 22A, a cell lysis chamber 22B, a filter region 24, a PCR reaction chamber comprising sections 22C and 22D, and a fractal detection region 40. The mesoscale flow system 20 is also provided with fluid entry/ exit ports 16A, 16B, 16C and 16D. The device is used in combination with an appliance, such as appliance 50, shown in FIG. 6A.
  • Initially, the valves in the appliance are used to close ports 16C and 16D, while ports 16A and 16B are open. A sample containing a mixture of cells is. directed to the sample inlet port 16A by the pump 52 in the appliance, and flows through the mesoscale flow path 20 to separation chamber 22A. Chamber 22A contains binding moieties immobilized on the wall of the chamber which selectively bind to a surface molecule on a desired type of cell in the sample. Remaining cellular components exit the substrate via port 16B. After binding of the desired cell population in chamber 22A, flow with buffer is continued, to wash and assure isolation of the cell population. Next port 6B is closed and 16C is opened. Flow is then increased sufficiently to dislodge the immobilized cells. Flow is continued, forcing cells through membrane piercing protrusions 90 in chamber 22B, which tear open the cells releasing intracellular material.
  • Sample flow continues past filter 24, which filters off large cellular membrane components and other debris, to mesoscale PCR chamber section 22C, which is connected to PCR chamber section 22D by flow channel 20B. Taq polymerase, primers and other reagents required for the PCR assay next are added to section 22D through port 16C from a mated port and flow path in the appliance, permitting mixing of the intracellular soluble components from the separated subpopulation of cells and the PCR reagents. With port 16A closed, a pump in the appliance connected via port 16B is used to cycle the PCR sample and reagents through flow channel 20B between sections 22C and 22D, set at 94° C. and 65° C. respectively, to implement plural polynucleotide melting and polymerization cycles, allowing the amplification of product polynucleotide. The valves in the appliance next are used to close port 16C and to open port 16D. The pump in the appliance connected to port 16B is then used to direct the amplified polynucleotide isolated from the cell population to a detection region comprised of a fractally bifurcating series of flow paths 40. Flow restriction in the fractal region 40 serves as a. positive indicator of the presence of amplified polynucleotide product and is detected optically through a glass cover disposed over the detection region.
  • It will be understood that the above descriptions are made by way of illustration, and that the invention may take other forms within the spirit of the structures and methods described herein. Variations and modifications will occur to those skilled in the art, and all such variations and modifications are considered to be part of the invention, as defined in the claims.

Claims (26)

1. an analytical system for PCR analysis comprising:
a device comprising a mesoscale flow system and an inlet port communicating with the flow system;
an appliance comprising a nesting site that releasably holds the device, a flow line mating with the inlet port of the device, a pump connected to the flow line that when actuated forces fluid through the flow system of the device, and a sensor that detects properties of fluid within the flow system; and
means for thermally cycling fluid within the flow system.
2. The system of claim 1, wherein the device comprises a solid substrate.
3. The system of claim 2, wherein the solid substrate is approximately 0.2 to 2.0 centimeters square.
4. The system of claim 2, wherein the device further comprises a cover.
5. The system of claim 4, wherein the cover is a transparent cover.
6. The system of claim 2, wherein the solid substrate comprises silicon.
7. The system of claim 2, wherein the solid substrate comprises a polymer.
8. The system of claim 1, wherein the mesoscale flow system comprises a flow channel extending from the inlet port and in fluid communication with a reaction chamber.
9. The system of claim 8, wherein the reaction chamber has a larger cross-sectional dimension than the flow channel.
10. The system of claim 8, wherein the reaction chamber has a cross-sectional width of 1-5 mm.
11. The system of claim 9, wherein the reaction chamber has a cross-sectional depth of 2-50 μm.
12. The system of claim 1, wherein the sensor is capable of detecting changes in optical properties of fluid within the flow system.
13. The system of claim 12, wherein the sensor is a spectrophotometer.
14. The system of claim 12, wherein the sensor comprises a video camera.
15. The system of claim 1, wherein the sensor is a pressure detector.
16. The system of claim 1, wherein the sensor is an electrical conductivity sensor.
17. The system of claim 1, wherein the appliance comprises a magnetic source.
18. The system of claim 1, wherein the appliance comprises electrical contacts in the nesting site, the device comprises electrical contacts, and the electrical contacts in the appliance mate with electrical contacts on the device when the device is placed in the nesting site.
19. The system of claim 18, wherein the appliance is configured to transmit electrical energy to the device.
20. The system of claim 18, wherein the appliance is configured to receive electrical signals from the device.
21. The system of claim 1, wherein the nesting site comprises a heating element.
22. The system of claim 1, wherein the nesting site comprises a cooling element.
23. The system of claim 1, wherein the device comprises multiple inlet ports.
24. The system of claim 8, wherein the means for thermally cycling fluid comprises a heating/cooling element within the reaction chamber.
25. The system of claim 19, wherein the device comprises a solid substrate, and wherein the means for thermally cycling fluid comprises an electrical heating element integrated into the substrate.
26. The system of claim 1, wherein the sensor is a thermocouple.
US11/696,926 1992-05-01 2007-04-05 Mesoscale polynucleotide amplification device and method Abandoned US20070190641A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/696,926 US20070190641A1 (en) 1992-05-01 2007-04-05 Mesoscale polynucleotide amplification device and method

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US87766292A 1992-05-01 1992-05-01
US08/308,199 US5498392A (en) 1992-05-01 1994-09-19 Mesoscale polynucleotide amplification device and method
US08/614,242 US5955029A (en) 1992-05-01 1996-03-12 Mesoscale polynucleotide amplification device and method
US09/212,029 US6953676B1 (en) 1992-05-01 1998-12-15 Mesoscale polynucleotide amplification device and method
US11/247,732 US20060040309A1 (en) 1992-05-01 2005-10-11 Mesoscale polynucleotide amplification analysis
US11/696,926 US20070190641A1 (en) 1992-05-01 2007-04-05 Mesoscale polynucleotide amplification device and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/247,732 Continuation US20060040309A1 (en) 1992-05-01 2005-10-11 Mesoscale polynucleotide amplification analysis

Publications (1)

Publication Number Publication Date
US20070190641A1 true US20070190641A1 (en) 2007-08-16

Family

ID=29219920

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/212,029 Expired - Fee Related US6953676B1 (en) 1992-05-01 1998-12-15 Mesoscale polynucleotide amplification device and method
US10/426,674 Expired - Fee Related US7494770B2 (en) 1992-05-01 2003-04-30 Mesoscale polynucleotide amplification analysis
US11/247,732 Abandoned US20060040309A1 (en) 1992-05-01 2005-10-11 Mesoscale polynucleotide amplification analysis
US11/696,926 Abandoned US20070190641A1 (en) 1992-05-01 2007-04-05 Mesoscale polynucleotide amplification device and method

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US09/212,029 Expired - Fee Related US6953676B1 (en) 1992-05-01 1998-12-15 Mesoscale polynucleotide amplification device and method
US10/426,674 Expired - Fee Related US7494770B2 (en) 1992-05-01 2003-04-30 Mesoscale polynucleotide amplification analysis
US11/247,732 Abandoned US20060040309A1 (en) 1992-05-01 2005-10-11 Mesoscale polynucleotide amplification analysis

Country Status (1)

Country Link
US (4) US6953676B1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019379A1 (en) * 2000-05-30 2006-01-26 Cepheid Apparatus and method for cell disruption
US20060030038A1 (en) * 1999-05-28 2006-02-09 Chpheid Apparatus and method for cell disruption
US20060027686A1 (en) * 1999-05-28 2006-02-09 Cepheid Apparatus and method for cell disruption
US20060094028A1 (en) * 2004-11-04 2006-05-04 Welch Allyn, Inc. Rapid diagnostic assay
WO2009069023A2 (en) * 2007-11-29 2009-06-04 International Business Machines Corporation Apparatus and method for detection of an analyte in a sample
US20090317874A1 (en) * 2008-06-23 2009-12-24 Canon U.S. Life Sciences, Inc. Systems and methods for amplifying nucleic acids
WO2010115531A1 (en) * 2009-04-09 2010-10-14 Bayer Technology Services Gmbh Single-use microfluidic test cartridge for the bioassay of analytes
US9499847B2 (en) 2010-08-04 2016-11-22 Touchlight IP Limited Production of closed linear DNA using a palindromic sequence
CN106256435A (en) * 2015-06-17 2016-12-28 台达电子工业股份有限公司 Centrifugal flow passage device and centrifugal runner body
US9789481B2 (en) 1999-05-28 2017-10-17 Cepheid Device for extracting nucleic acid from a sample
US10501782B1 (en) 2014-09-05 2019-12-10 Touchlight IP Limited Cell-free synthesis of DNA by strand displacement
US11384388B2 (en) 2009-01-30 2022-07-12 Touchlight IP Limited DNA vaccines

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637469A (en) * 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems
US6048734A (en) 1995-09-15 2000-04-11 The Regents Of The University Of Michigan Thermal microvalves in a fluid flow method
US7244622B2 (en) * 1996-04-03 2007-07-17 Applera Corporation Device and method for multiple analyte detection
GB2368809B (en) * 2000-09-15 2004-09-29 Norchip As Microfabricated reaction chamber system
US6692700B2 (en) 2001-02-14 2004-02-17 Handylab, Inc. Heat-reduction methods and systems related to microfluidic devices
US7010391B2 (en) 2001-03-28 2006-03-07 Handylab, Inc. Methods and systems for control of microfluidic devices
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US6852287B2 (en) 2001-09-12 2005-02-08 Handylab, Inc. Microfluidic devices having a reduced number of input and output connections
US7829025B2 (en) 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
US6889468B2 (en) * 2001-12-28 2005-05-10 3M Innovative Properties Company Modular systems and methods for using sample processing devices
US7341652B2 (en) * 2003-06-20 2008-03-11 Groton Biosytems, Llc Stationary capillary electrophoresis system
EP2402089A1 (en) 2003-07-31 2012-01-04 Handylab, Inc. Processing particle-containing samples
US20050112545A1 (en) * 2003-11-24 2005-05-26 Chapman Charles B. Method and device for sanitizing disposable biochips
ES2432040T3 (en) * 2004-01-28 2013-11-29 454 Life Sciences Corporation Nucleic acid amplification with continuous flow emulsion
DE102004005193B4 (en) * 2004-02-02 2006-08-24 Medion Diagnostics Gmbh Device for separating individual particles from particle agglutinations
US20050249641A1 (en) * 2004-04-08 2005-11-10 Boehringer Ingelheim Microparts Gmbh Microstructured platform and method for manipulating a liquid
EP2345739B8 (en) 2004-05-03 2016-12-07 Handylab, Inc. A microfluidic device for processing polynucleotide-containing samples
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
US7622296B2 (en) 2004-05-28 2009-11-24 Wafergen, Inc. Apparatus and method for multiplex analysis
US20060171855A1 (en) * 2005-02-03 2006-08-03 Hongfeng Yin Devices,systems and methods for multi-dimensional separation
EP2597472A3 (en) * 2005-04-01 2014-03-05 Konica Minolta Medical & Graphic, Inc. Micro integrated analysis system, testing chip, and testing method
US20060280029A1 (en) * 2005-06-13 2006-12-14 President And Fellows Of Harvard College Microfluidic mixer
US20070137062A1 (en) * 2005-07-05 2007-06-21 Eck Gary A Increased Negative Static Pressure Drying
WO2007021816A2 (en) * 2005-08-11 2007-02-22 Eksigent Technologies, Llc Methods and apparatuses for reducing effects of molecule adsorption within microfluidic channels
EP1928570B1 (en) 2005-08-22 2015-04-15 Life Technologies Corporation Apparatus, system, and method using immiscible-fluid-discrete-volumes
CA2622416A1 (en) * 2005-09-14 2007-03-22 Symyx Technologies, Inc. Microscale flash separation of fluid mixtures
US8703445B2 (en) * 2005-12-29 2014-04-22 Abbott Point Of Care Inc. Molecular diagnostics amplification system and methods
TWI307714B (en) * 2006-01-13 2009-03-21 Ind Tech Res Inst Self-sealing high-temperature biochemical reaction apparatus and method for the same
EP2007905B1 (en) 2006-03-15 2012-08-22 Micronics, Inc. Integrated nucleic acid assays
EP2001990B1 (en) * 2006-03-24 2016-06-29 Handylab, Inc. Integrated system for processing microfluidic samples, and method of using same
US8088616B2 (en) 2006-03-24 2012-01-03 Handylab, Inc. Heater unit for microfluidic diagnostic system
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US7629124B2 (en) * 2006-06-30 2009-12-08 Canon U.S. Life Sciences, Inc. Real-time PCR in micro-channels
WO2008094198A2 (en) * 2006-07-28 2008-08-07 Biosite Incorporated Devices and methods for performing receptor binding assays using magnetic particles
WO2008060604A2 (en) * 2006-11-14 2008-05-22 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
EP2091647A2 (en) 2006-11-14 2009-08-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US20080152543A1 (en) * 2006-11-22 2008-06-26 Hideyuki Karaki Temperature regulation method of microfluidic chip, sample analysis system and microfluidic chip
AU2008209561A1 (en) 2007-01-22 2008-07-31 Wafergen, Inc. Apparatus for high throughput chemical reactions
US9152150B1 (en) 2007-02-22 2015-10-06 Applied Biosystems, Llc Compositions, systems, and methods for immiscible fluid discrete volume manipulation
US20100112579A1 (en) * 2007-03-26 2010-05-06 Fundacion Gaiker Method and device for the detection of genetic material by polymerase chain reaction
US20090136385A1 (en) * 2007-07-13 2009-05-28 Handylab, Inc. Reagent Tube
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
USD621060S1 (en) 2008-07-14 2010-08-03 Handylab, Inc. Microfluidic cartridge
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
EP3741869A1 (en) 2007-07-13 2020-11-25 Handylab, Inc. Polynucleotide capture materials and methods of using same
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US20100009351A1 (en) * 2008-07-11 2010-01-14 Handylab, Inc. Polynucleotide Capture Materials, and Method of Using Same
USD618820S1 (en) 2008-07-11 2010-06-29 Handylab, Inc. Reagent holder
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
WO2009118015A2 (en) * 2008-08-01 2009-10-01 Smart Biosystems Aps A sample port of a cell culture system
DE112010002222B4 (en) 2009-06-04 2024-01-25 Leidos Innovations Technology, Inc. (n.d.Ges.d. Staates Delaware) Multi-sample microfluidic chip for DNA analysis
CA2786569C (en) 2010-01-29 2019-04-09 Micronics, Inc. Sample-to-answer microfluidic cartridge
US8511889B2 (en) * 2010-02-08 2013-08-20 Agilent Technologies, Inc. Flow distribution mixer
US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design
ES2769028T3 (en) 2011-04-15 2020-06-24 Becton Dickinson Co Real-time scanning microfluidic thermocycler
CA2849917C (en) 2011-09-30 2020-03-31 Becton, Dickinson And Company Unitized reagent strip
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
EP2773892B1 (en) 2011-11-04 2020-10-07 Handylab, Inc. Polynucleotide sample preparation device
RU2658773C2 (en) 2012-02-03 2018-06-22 Бектон, Дикинсон Энд Компани System and method of implementation of automated assays on plurality of biological samples
KR101915675B1 (en) * 2012-02-07 2018-11-06 주식회사 미코바이오메드 ultra-fast device for the extraction of nucleic acids, and the method for the extraction of nucleic acids using the same
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
EP4219012A1 (en) * 2012-04-03 2023-08-02 Illumina, Inc. Method of imaging a substrate comprising fluorescent features and use of the method in nucleic acid sequencing
CN102886280B (en) * 2012-08-28 2014-06-11 博奥生物有限公司 Microfluidic chip and application thereof
KR102102123B1 (en) 2012-12-21 2020-04-20 퍼킨엘머 헬스 사이언시즈, 아이엔씨. Fluidic circuits and related manufacturing methods
WO2014100725A1 (en) 2012-12-21 2014-06-26 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
CN107824233B (en) 2012-12-21 2020-06-30 珀金埃尔默健康科学有限公司 Low elasticity membranes for microfluidic applications
CN105189784B (en) 2013-05-07 2020-06-30 珀金埃尔默健康科学有限公司 Device for preparing and analyzing nucleic acids
WO2014182844A1 (en) 2013-05-07 2014-11-13 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
CA2911303C (en) 2013-05-07 2021-02-16 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
US9387451B2 (en) 2014-02-03 2016-07-12 International Business Machines Corporation Flow cell array and uses thereof
CN106662569B (en) * 2014-06-07 2020-02-28 艾西里昂公司 Micromachined sensor and method for detecting components in body fluids
WO2016134342A1 (en) 2015-02-20 2016-08-25 Wafergen, Inc. Method for rapid accurate dispensing, visualization and analysis of single cells
EP3487616B1 (en) 2016-07-21 2023-08-09 Takara Bio USA, Inc. Multi-z imaging of wells of multi-well devices and liquid dispensing into the wells
WO2019079725A1 (en) * 2017-10-19 2019-04-25 Georgia Tech Research Corporation Mesofluidic device for culture of cell aggregates
CN109248722A (en) * 2018-11-20 2019-01-22 京东方科技集团股份有限公司 A kind of preparation method of covering plate structure, micro fluidic device and covering plate structure
CN112080806B (en) * 2020-10-23 2024-02-20 江苏吉诺思美精准医学科技有限公司 Plasma free DNA library construction method of capillary 96-well plate

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3799742A (en) * 1971-12-20 1974-03-26 C Coleman Miniaturized integrated analytical test container
US3836255A (en) * 1972-04-06 1974-09-17 M Schuman Spectrometric substance analyzer employing temperature modulation
US4233029A (en) * 1978-10-25 1980-11-11 Eastman Kodak Company Liquid transport device and method
US4302313A (en) * 1979-07-23 1981-11-24 Eastman Kodak Company Electrode-containing device with capillary transport between electrodes
US4618476A (en) * 1984-02-10 1986-10-21 Eastman Kodak Company Capillary transport device having speed and meniscus control means
US4886761A (en) * 1987-03-26 1989-12-12 Yellowstone Diagnostics Corporation Polysilicon binding assay support and methods
US4908112A (en) * 1988-06-16 1990-03-13 E. I. Du Pont De Nemours & Co. Silicon semiconductor wafer for analyzing micronic biological samples
US4911782A (en) * 1988-03-28 1990-03-27 Cyto-Fluidics, Inc. Method for forming a miniaturized biological assembly
US4963498A (en) * 1985-08-05 1990-10-16 Biotrack Capillary flow device
US5135720A (en) * 1989-05-23 1992-08-04 Seiko Instruments Inc. Reaction chamber for amino-terminal sequence analysis of proteins or peptides
US5147607A (en) * 1989-11-30 1992-09-15 Mochida Pharmaceutical Co., Ltd. Reaction vessel with a rocking base
US5147606A (en) * 1990-08-06 1992-09-15 Miles Inc. Self-metering fluid analysis device
US5176203A (en) * 1989-08-05 1993-01-05 Societe De Conseils De Recherches Et D'applications Scientifiques Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
US5188963A (en) * 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5266272A (en) * 1991-10-31 1993-11-30 Baxter Diagnostics Inc. Specimen processing and analyzing systems with a station for holding specimen trays during processing
US5270183A (en) * 1991-02-08 1993-12-14 Beckman Research Institute Of The City Of Hope Device and method for the automated cycling of solutions between two or more temperatures
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5346672A (en) * 1989-11-17 1994-09-13 Gene Tec Corporation Devices for containing biological specimens for thermal processing
US5460780A (en) * 1989-06-12 1995-10-24 Devaney, Jr.; Mark J. Temperature control device and reaction vessel
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055468A (en) * 1974-02-28 1977-10-25 Sanraku-Ocean Co., Ltd. Processes for producing physiologically active peptide and its N-acyl derivatives
US5059654A (en) * 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
US4743535A (en) * 1984-11-07 1988-05-10 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
US4756884A (en) 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4790640A (en) 1985-10-11 1988-12-13 Nason Frederic L Laboratory slide
AU604684B2 (en) * 1986-03-20 1991-01-03 Gen-Probe Incorporated Method for releasing RNA and DNA from cells
GB2191110B (en) * 1986-06-06 1989-12-06 Plessey Co Plc Chromatographic separation device
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
JP2993982B2 (en) 1988-10-21 1999-12-27 モレキユラー デヴアイシズ コーポレイシヨン Method and apparatus for detecting the effect of a cell-acting agent on living cells
GB8903046D0 (en) 1989-02-10 1989-03-30 Vale David R Testing of liquids
DE3915920A1 (en) 1989-05-16 1990-11-22 Messerschmitt Boelkow Blohm Micro-mechanical structures for storing and testing substances - e.g. for disease diagnosis, is made of inert material, e.g. glass, and has defined pattern of depressions, cavities, etc.
CA2016981C (en) 1989-06-12 1994-09-27 Mark Joseph Devaney, Jr. Temperature control device and reaction vessel
CA2035010C (en) 1990-01-26 1996-12-10 Keith C. Backman Method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions
WO1991013338A2 (en) 1990-02-24 1991-09-05 Hatfield Polytechnic Higher Education Corporation Biorheological measurement
GB9008044D0 (en) 1990-04-09 1990-06-06 Hatfield Polytechnic Higher Ed Microfabricated device for biological cell sorting
SE470347B (en) 1990-05-10 1994-01-31 Pharmacia Lkb Biotech Microstructure for fluid flow systems and process for manufacturing such a system
EP0620863B1 (en) 1991-12-24 2000-05-03 Tepnel Medical Limited Manipulating nucleic acid sequences
US5223219A (en) * 1992-04-10 1993-06-29 Biotrack, Inc. Analytical cartridge and system for detecting analytes in liquid samples
US5639423A (en) 1992-08-31 1997-06-17 The Regents Of The University Of Calfornia Microfabricated reactor
US5720183A (en) * 1996-09-17 1998-02-24 General Electric Company Water trap cup

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3799742A (en) * 1971-12-20 1974-03-26 C Coleman Miniaturized integrated analytical test container
US3836255A (en) * 1972-04-06 1974-09-17 M Schuman Spectrometric substance analyzer employing temperature modulation
US4233029A (en) * 1978-10-25 1980-11-11 Eastman Kodak Company Liquid transport device and method
US4302313A (en) * 1979-07-23 1981-11-24 Eastman Kodak Company Electrode-containing device with capillary transport between electrodes
US4618476A (en) * 1984-02-10 1986-10-21 Eastman Kodak Company Capillary transport device having speed and meniscus control means
US4963498A (en) * 1985-08-05 1990-10-16 Biotrack Capillary flow device
US4886761A (en) * 1987-03-26 1989-12-12 Yellowstone Diagnostics Corporation Polysilicon binding assay support and methods
US4911782A (en) * 1988-03-28 1990-03-27 Cyto-Fluidics, Inc. Method for forming a miniaturized biological assembly
US4908112A (en) * 1988-06-16 1990-03-13 E. I. Du Pont De Nemours & Co. Silicon semiconductor wafer for analyzing micronic biological samples
US5229297A (en) * 1989-02-03 1993-07-20 Eastman Kodak Company Containment cuvette for PCR and method of use
US5135720A (en) * 1989-05-23 1992-08-04 Seiko Instruments Inc. Reaction chamber for amino-terminal sequence analysis of proteins or peptides
US5460780A (en) * 1989-06-12 1995-10-24 Devaney, Jr.; Mark J. Temperature control device and reaction vessel
US5176203A (en) * 1989-08-05 1993-01-05 Societe De Conseils De Recherches Et D'applications Scientifiques Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
US5188963A (en) * 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids
US5346672A (en) * 1989-11-17 1994-09-13 Gene Tec Corporation Devices for containing biological specimens for thermal processing
US5147607A (en) * 1989-11-30 1992-09-15 Mochida Pharmaceutical Co., Ltd. Reaction vessel with a rocking base
US5147606A (en) * 1990-08-06 1992-09-15 Miles Inc. Self-metering fluid analysis device
US5270183A (en) * 1991-02-08 1993-12-14 Beckman Research Institute Of The City Of Hope Device and method for the automated cycling of solutions between two or more temperatures
US5266272A (en) * 1991-10-31 1993-11-30 Baxter Diagnostics Inc. Specimen processing and analyzing systems with a station for holding specimen trays during processing
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5955029A (en) * 1992-05-01 1999-09-21 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8268603B2 (en) * 1999-05-28 2012-09-18 Cepheid Apparatus and method for cell disruption
US20060030038A1 (en) * 1999-05-28 2006-02-09 Chpheid Apparatus and method for cell disruption
US20060027686A1 (en) * 1999-05-28 2006-02-09 Cepheid Apparatus and method for cell disruption
US9943848B2 (en) 1999-05-28 2018-04-17 Cepheid Apparatus and method for cell disruption
US9789481B2 (en) 1999-05-28 2017-10-17 Cepheid Device for extracting nucleic acid from a sample
US9073053B2 (en) 1999-05-28 2015-07-07 Cepheid Apparatus and method for cell disruption
US20060019379A1 (en) * 2000-05-30 2006-01-26 Cepheid Apparatus and method for cell disruption
US8815521B2 (en) * 2000-05-30 2014-08-26 Cepheid Apparatus and method for cell disruption
US20060094028A1 (en) * 2004-11-04 2006-05-04 Welch Allyn, Inc. Rapid diagnostic assay
US20060178568A1 (en) * 2004-11-04 2006-08-10 Dominick Danna Rapid diagnostic assay
WO2009069023A3 (en) * 2007-11-29 2009-07-16 Ibm Apparatus and method for detection of an analyte in a sample
US9594082B2 (en) 2007-11-29 2017-03-14 International Business Machines Corporation Apparatus and method for detection of an analyte in a sample
WO2009069023A2 (en) * 2007-11-29 2009-06-04 International Business Machines Corporation Apparatus and method for detection of an analyte in a sample
JP2011505555A (en) * 2007-11-29 2011-02-24 インターナショナル・ビジネス・マシーンズ・コーポレーション Apparatus and method for detecting an analyte in a sample
US9005887B2 (en) 2007-11-29 2015-04-14 International Business Machines Corporation Detection of an analyte in a sample
US9012136B2 (en) 2007-11-29 2015-04-21 International Business Machines Corporation Detection of an analyte in a sample
US9724695B2 (en) * 2008-06-23 2017-08-08 Canon U.S. Life Sciences, Inc. Systems and methods for amplifying nucleic acids
US20090317874A1 (en) * 2008-06-23 2009-12-24 Canon U.S. Life Sciences, Inc. Systems and methods for amplifying nucleic acids
US10632470B2 (en) 2008-06-23 2020-04-28 Canon U.S.A., Inc. Systems and methods for amplifying nucleic acids
US11384388B2 (en) 2009-01-30 2022-07-12 Touchlight IP Limited DNA vaccines
WO2010115531A1 (en) * 2009-04-09 2010-10-14 Bayer Technology Services Gmbh Single-use microfluidic test cartridge for the bioassay of analytes
CN102387863A (en) * 2009-04-09 2012-03-21 拜尔技术服务有限责任公司 Single-use microfluidic test cartridge for the bioassay of analytes
US20120040470A1 (en) * 2009-04-09 2012-02-16 Bayer Technology Services Gmbh Single-use microfluidic test cartridge for the bioassay of analytes
US9499847B2 (en) 2010-08-04 2016-11-22 Touchlight IP Limited Production of closed linear DNA using a palindromic sequence
US10501782B1 (en) 2014-09-05 2019-12-10 Touchlight IP Limited Cell-free synthesis of DNA by strand displacement
CN106256435A (en) * 2015-06-17 2016-12-28 台达电子工业股份有限公司 Centrifugal flow passage device and centrifugal runner body

Also Published As

Publication number Publication date
US20060040309A1 (en) 2006-02-23
US20030199081A1 (en) 2003-10-23
US7494770B2 (en) 2009-02-24
US6953676B1 (en) 2005-10-11

Similar Documents

Publication Publication Date Title
US6953676B1 (en) Mesoscale polynucleotide amplification device and method
US5955029A (en) Mesoscale polynucleotide amplification device and method
EP0637999B1 (en) Polynucleotide amplification analysis using a microfabricated device
US7892819B2 (en) Mesoscale polynucleotide amplification devices
EP0739423B1 (en) Mesoscale polynucleotide amplification devices
US5635358A (en) Fluid handling methods for use in mesoscale analytical devices
US5486335A (en) Analysis based on flow restriction
US5866345A (en) Apparatus for the detection of an analyte utilizing mesoscale flow systems
AU698213C (en) Mesoscale polynucleotide amplification devices
MXPA96002775A (en) Amplification devices, medium scale, polinucleoti

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION